{
  "meta": {
    "title": "00241_Late_Night_Pyqs_Inicet_-_6",
    "url": "https://brainandscalpel.vercel.app/00241-late-night-pyqs-inicet-6-bf8ca99e.html",
    "scrapedAt": "2025-11-29T18:10:30.476Z"
  },
  "questions": [
    {
      "id": 7157,
      "choices": [
        {
          "id": 28596,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 28597,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2</span></span></span></p>"
        },
        {
          "id": 28598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3, 4</span></span></span></p>"
        },
        {
          "id": 28599,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding memantine? (INICET NOV 2022)</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Its therapeutic effect is due to its antagonistic action on NMDA receptors.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. It is reserved for moderate-to-severe cases of Alzheimer&rsquo;s disease.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. It is used only as a monotherapy and should not be used with cholinesterase inhibitors.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. It is given at a daily dose of 20-30 mg/day.</span></span></span></span></p>",
      "unique_key": "Q7074005",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250563,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. 1, 2</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Its therapeutic effect is due to its antagonistic action on NMDA receptors:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True. Memantine is an NMDA (N-methyl-D-aspartate) receptor antagonist. It works by blocking the action of glutamate at the NMDA receptors, which is thought to play a role in the symptoms of Alzheimer&#39;s disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. It is reserved for moderate-to-severe cases of Alzheimer&rsquo;s disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True. Memantine is typically used in the treatment of moderate to severe Alzheimer&#39;s disease. It is not commonly used in the early stages of the disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. It is used only as a monotherapy and should not be used with cholinesterase inhibitors: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False. Memantine can be used alone (as monotherapy) or in combination with cholinesterase inhibitors, such as donepezil, rivastigmine, or galantamine, in the treatment of Alzheimer&#39;s disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. It is given at a daily dose of 20-30 mg/day: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False. Memantine is started at a lower dose of 5 mg daily and is titrated up to a target dose, which is usually 20 mg/day. Therefore, it is more precise to say that the standard dose is up to 20 mg/day.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Memantine is an NMDA receptor antagonist used for moderate to severe Alzheimer&#39;s disease. It can be used alone or in combination with cholinesterase inhibitors, and the standard maximum dose is 20 mg/day.</span></span></span></p>",
      "correct_choice_id": 28597,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10236,
      "choices": [
        {
          "id": 40910,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-d, 4-a</span></span></span></p>"
        },
        {
          "id": 40911,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-b, 3-d, 4-c</span></span></span></p>"
        },
        {
          "id": 40912,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-a, 4-b</span></span></span></p>"
        },
        {
          "id": 40913,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-b, 3-d, 4-a</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following scale types with their lesions?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13558_1YHi2Nx.jpg\" style=\"height:200px; width:800px\" /></span></span></p>",
      "unique_key": "Q3481811",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250559,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-b, 2-c, 3-d, 4-a</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Matched Pairs:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">1-b: Collarette scales - Pityriasis Rosea:</span>&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Collarette scales are characteristic of Pityriasis Rosea, where these scales are fine, peripherally attached but centrally detached, often found around the edge of the herald patch or subsequent lesions.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">2-c: Silvery scales - Psoriasis</span>:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Silvery scales are hallmark features of Psoriasis. These scales are typically seen as thick, shiny, and silvery white, indicative of excessive proliferation of skin layers, particularly due to parakeratosis.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">3-d: Mica-like scales - Pityriasis lichenoides chronica:</span>&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mica-like scales in Pityriasis lichenoides chronica refer to the fine, adherent scales that resemble mineral mica, found on polymorphic lesions that can also show hemorrhagic crusting.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">4-a: Branny scales - Pityriasis versicolor</span>:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branny scales are a feature of Pityriasis versicolor, described as fine, powdery, and often easily detachable, much like bran. These scales highlight the superficial fungal infection&#39;s impact on the skin.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture8.jpg\" style=\"height:177px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture9_6tWtHra.jpg\" style=\"height:229px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture10.jpg\" style=\"height:271px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture11.jpg\" style=\"height:249px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture12_BOpEZzo.jpg\" style=\"height:205px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture14.jpg\" style=\"height:253px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture15.jpg\" style=\"height:232px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diseases &amp; special scales:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-181649.png\" style=\"height:445px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref - Rook&#39;s Textbook of Dermatology -9th Edition Chapter 28 Page no 4.13, 26.2, 29.15, 40.1-40.5, 50.6, 65.2, 107.3, 109.8</span></strong></span></span></p>",
      "correct_choice_id": 40910,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13067,
      "choices": [
        {
          "id": 52230,
          "text": "<p><span style=\"font-size:12.0pt;\">Durham's rule</span></p>"
        },
        {
          "id": 52231,
          "text": "<p><span style=\"font-size:12.0pt;\">Curren's rule</span></p>"
        },
        {
          "id": 52232,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        },
        {
          "id": 52233,
          "text": "<p><span style=\"font-size:12.0pt;\">Neither A nor B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following rules of law are associated with insanity? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p>",
      "unique_key": "Q2704458",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250556,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Both A and B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Durham's rule and Curren's rule are laws associated with insanity.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Curren's rule of 1964 states that an accused person is not criminally responsible, if at the time of committing the act, he did not have the capacity to regulate his conduct to the requirements of the law, as a result of mental disease or defect.</span></li><li><span style=\"font-size:12.0pt;\">Durham 's rule of 1954 States that an accused person is not criminally responsible if his unlawful act is the product of mental disease or mental defect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Both Durham's rule and Curren's rule are significant tests used to determine criminal responsibility in cases where the defendant's mental state is in question.</span></p>",
      "correct_choice_id": 52232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10218,
      "choices": [
        {
          "id": 40838,
          "text": "<p><span style=\"font-size:12pt;\">KOH mount</span></p>"
        },
        {
          "id": 40839,
          "text": "<p><span style=\"font-size:12pt;\">Slit skin smear</span></p>"
        },
        {
          "id": 40840,
          "text": "<p><span style=\"font-size:12pt;\">Gram staining</span></p>"
        },
        {
          "id": 40841,
          "text": "<p><span style=\"font-size:12pt;\">Biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents to you with itchy lesions on the scalp with hair loss as shown in the image below. What would be the next best step? (</span>INICET Nov 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-1347.jpg\" alt=\"\" width=\"250\" height=\"314\"></span></p>",
      "unique_key": "Q3009068",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250498,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;A) KOH mount</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image shows <strong>itchy</strong> lesions on the <strong>scalp</strong> with <strong>hair loss</strong> which is suggestive of a <strong>fungal</strong> infection, commonly <strong>tinea capitis</strong>.</span></li><li><span style=\"font-size:12pt;\">The next best step in confirming the diagnosis would be to do a <strong>KOH mount</strong>.</span></li><li><span style=\"font-size:12pt;\">The potassium hydroxide (KOH) preparation is used to visualize <strong>fungal</strong> elements in <strong>skin, hair, and nail</strong> samples.</span></li><li><span style=\"font-size:12pt;\">When applied, <strong>KOH </strong>dissolves the <strong>keratin</strong> in the skin, hair, and nails, <strong>leaving only fungal cells intact</strong>, which can then be visualized under the microscope.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Tinea capitis variants:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-160011.png\" alt=\"\" width=\"900\" height=\"101\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Ectothrix -&nbsp;</strong>Spores &amp; fungus present outside the hair shaft.</span></li><li><span style=\"font-size:12pt;\"><strong>Endothrix -&nbsp;</strong>Spores &amp; fungi present inside the hair shaft.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-160143.png\" alt=\"\" width=\"300\" height=\"304\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-160300.png\" alt=\"\" width=\"900\" height=\"282\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Kerion</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Presents in Children with <strong>boggy swelling, easily pluckable hair, with regional lymphadenopathy.</strong></span></li><li><span style=\"font-size:12pt;\">It is a severe inflammatory type of tinea capitis.</span></li><li><span style=\"font-size:12pt;\">The <strong>most common causative organisms of kerion are Zoophilic dermatophytes</strong>, T. verrucosum and T. mentagrophytes. In severe cases, there may be pus along with sinus formation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-160359.png\" alt=\"\" width=\"350\" height=\"305\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Fig: Lesion: Boggy indurated scalp swelling</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Investigation:&nbsp;</strong>10% KOH mount</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment:&nbsp;</strong>DOC overall and for Microsporum is Griseofulvin</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Note: DOC for Trichophyton is Terbinafine.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Slit skin smear (SSS):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a procedure mainly used for diagnosing <strong>leprosy.</strong></span></li><li><span style=\"font-size:12pt;\">It involves taking a <strong>smear </strong>from the skin, usually from the <strong>earlobe</strong>, to look for <strong>acid-fast bacilli</strong>.</span></li><li><span style=\"font-size:12pt;\">It is not appropriate in this case where fungal infection is suspected.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Gram staining:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a microbiological staining technique that is used to differentiate <strong>bacterial </strong>species into two large groups based on the chemical and physical properties of their cell walls.</span></li><li><span style=\"font-size:12pt;\">It's not the first line of investigation for suspected fungal infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Biopsy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While a biopsy can be used to diagnose various skin conditions, it is <strong>invasive</strong> and not the first line of investigation for a suspected fungal infection.</span></li><li><span style=\"font-size:12pt;\">A KOH mount is a much simpler and <strong>direct test</strong> to confirm the presence of fungus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For <strong>itchy lesions</strong> on the scalp with hair loss suggestive of <strong>tinea capitis</strong>, a <strong>KOH mount</strong> is the preferred initial test to <strong>visualize fungal</strong> elements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology - Volume II-9th Edition Chapter 32 Page no 32.38, 32.40</strong></span></p>",
      "correct_choice_id": 40838,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56217,
      "choices": [
        {
          "id": 224285,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 224286,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 224287,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 224288,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What would be seen if the central part of the cord was involved?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">LMN lesion of upper limbs and trunk and UMN of lower limbs.</span></li><li><span style=\"font-size:12.0pt;\">UMN lesion of upper limbs and trunk and LMN of lower limbs.</span></li><li><span style=\"font-size:12.0pt;\">Bladder and bowel involvement.</span></li><li><span style=\"font-size:12.0pt;\">Posterior tract involvement.</span></li></ol>",
      "unique_key": "Q5974792",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250499,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) 1 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Central cord lesions, such as those seen in conditions like syringomyelia and intramedullary tumors, present with a distinct pattern of neurological deficits due to the anatomical arrangement of the spinal tracts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. LMN lesion of upper limbs and trunk and UMN of lower limbs:</strong> This pattern is common in central cord syndromes, where there is damage to the anterior horn cells leading to lower motor neuron (LMN) lesions in the upper limbs. As the condition progresses, upper motor neuron (UMN) signs may appear in the lower limbs due to the involvement of the corticospinal tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Bladder and bowel involvement:</strong> Central cord lesions can affect autonomic functions leading to bladder and bowel dysfunction, especially in cases of extensive or progressive lesions like intramedullary tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. UMN lesion of upper limbs and trunk and LMN of lower limbs:</strong> This pattern is not typical for central cord syndromes. Usually, the upper limbs show LMN signs due to the involvement of the anterior horn cells, and the lower limbs show UMN signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Posterior tract involvement:</strong> Posterior tracts, which carry fine touch, vibration, and proprioception, are usually spared in central cord syndromes. These tracts are located more dorsally in the spinal cord, away from the central lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Central cord lesions, such as syringomyelia, typically present with LMN signs in the upper limbs, UMN signs in the lower limbs, and can involve bladder and bowel dysfunction, but they do not typically affect the posterior tracts</span></p>",
      "correct_choice_id": 224288,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54230,
      "choices": [
        {
          "id": 216389,
          "text": "<p><span style=\"font-size:12.0pt;\">Cochlear implant</span></p>"
        },
        {
          "id": 216390,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenoidectomy with grommet insertion</span></p>"
        },
        {
          "id": 216391,
          "text": "<p><span style=\"font-size:12.0pt;\">Making him sit in front row in class</span></p>"
        },
        {
          "id": 216392,
          "text": "<p><span style=\"font-size:12.0pt;\">Hearing aid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child has bilateral SNHL. Which of the following is not preferred in the child?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8060732",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250994,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Adenoidectomy with grommet insertion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenoidectomy with Grommet Insertion: This procedure is primarily used to treat chronic adenoiditis and otitis media with effusion (OME), which are associated with conductive hearing loss (CHL), not SNHL. Since the child has SNHL, this treatment is not appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bilateral sensorineural hearing loss (SNHL) indicates that there is a problem in the inner ear (cochlea) or the auditory nerve. When treating bilateral SNHL in a child, certain interventions are preferred based on the underlying pathology and the severity of the hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cochlear Implant:</strong> This is a viable option for children with severe to profound SNHL where the cochlea is affected but the auditory nerve is intact. The implant bypasses the damaged cochlea and directly stimulates the auditory nerve, allowing the child to hear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Making him sit in front row in class:</strong> This is a common accommodation to help children with hearing loss to better hear and engage in classroom activities. It minimizes the distance between the child and the teacher, thus reducing the impact of hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. &nbsp;Hearing Aid:</strong> This is suitable for children with mild to moderate SNHL. Hearing aids amplify sounds, making them louder and easier to hear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenoidectomy with grommet insertion is not preferred for treating bilateral sensorineural hearing loss as it addresses conditions causing conductive hearing loss, not sensorineural hearing loss.</span></p>",
      "correct_choice_id": 216390,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54763,
      "choices": [
        {
          "id": 218517,
          "text": "<p><span style=\"font-size:18px;\">Mental illness in children</span></p>"
        },
        {
          "id": 218518,
          "text": "<p><span style=\"font-size:18px;\">Schizophrenia and other psychotic disorders</span></p>"
        },
        {
          "id": 218519,
          "text": "<p><span style=\"font-size:18px;\">OCD</span></p>"
        },
        {
          "id": 218520,
          "text": "<p><span style=\"font-size:18px;\">Depression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Mental Health Gap Action (mhGAP) Program does not include:&nbsp;[</strong><i><strong>INICET MAY 2024]</strong></i></span></p>",
      "unique_key": "Q2303247",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250997,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) OCD</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Mental Health Gap Action Program (mhGAP) by the World Health Organization (WHO) is designed to scale up services for mental, neurological, and substance use disorders, particularly in low- and middle-income countries. The program focuses on priority conditions that are of high burden and can be managed effectively in primary care settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The mnemonic <strong>\"MESSI DAD\"</strong> can be used to remember the disorders included in the mhGAP program:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>M</strong>: Mental disorders in children (Option A)</span></li><li><span style=\"font-size:18px;\"><strong>E</strong>: Epilepsy</span></li><li><span style=\"font-size:18px;\"><strong>S</strong>: Suicide</span></li><li><span style=\"font-size:18px;\"><strong>S</strong>: Schizophrenia and other psychotic disorders (Option B)</span></li><li><span style=\"font-size:18px;\"><strong>I</strong>: Illicit drug use disorders</span></li><li><span style=\"font-size:18px;\"><strong>D</strong>: Depression (Option D)</span></li><li><span style=\"font-size:18px;\"><strong>A</strong>: Alcohol-related disorders</span></li><li><span style=\"font-size:18px;\"><strong>D</strong>: Dementia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Obsessive-Compulsive Disorder (OCD) is not included in the list of target conditions under the mhGAP program, which is why it is the correct answer to this question.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">OCD (Obsessive-Compulsive Disorder) is not included in the WHO's Mental Health Gap Action (mhGAP) program, which focuses on other high-burden mental health conditions.</span></p>",
      "correct_choice_id": 218519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11187,
      "choices": [
        {
          "id": 44714,
          "text": "<p><span style=\"font-size:18px;\">Sufficient component cause model</span></p>"
        },
        {
          "id": 44715,
          "text": "<p><span style=\"font-size:18px;\">Epidemiological triad</span></p>"
        },
        {
          "id": 44716,
          "text": "<p><span style=\"font-size:18px;\">PERT model</span></p>"
        },
        {
          "id": 44717,
          "text": "<p><span style=\"font-size:18px;\">Web of causation model</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Based on the depiction in the accompanying image, which model of disease causation is being illustrated? </strong><i><strong>[INICET NOV 2022]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip46.jpg\" alt=\"\" width=\"466\" height=\"463\"></strong></span></p>",
      "unique_key": "Q3785563",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Sufficient component cause model&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The model of disease causation depicted is a sufficient component cause model.</span></li><li><span style=\"font-size:18px;\">It was developed by Rothman based on the idea that an outcome can only happen when a sufficient cause is present.</span></li><li><span style=\"font-size:18px;\">A disease can have multiple sufficient causes. But each sufficient cause can consist of a pie chart of component causes, a causal pie.</span></li><li><span style=\"font-size:18px;\">One component cause can be a part of more than one sufficient cause.</span></li><li><span style=\"font-size:18px;\">A component cause can be considered necessary if it is a part of a disease's sufficient causes.</span></li><li><span style=\"font-size:18px;\">In the given model, each pie chart represents a sufficient cause made of component causes.</span></li><li><span style=\"font-size:18px;\">Since B is present in all the charts, it can be considered a necessary cause. All the others are contributing causes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.&nbsp;Epidemiological triad</strong>: An epidemiological triad depicts the interrelationship between the causative agent, the host, and the environment. All of them contribute to disease development. The aim of an epidemiological triad is to identify how to break this relationship and prevent the outbreak of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. PERT model</strong>: PERT is used for network analysis. It is a type of quantitative management technique that helps in detailed planning and comprehensive supervision.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture4444.jpg\" alt=\"\" width=\"500\" height=\"383\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Web of causation model:</strong> The web of causation considers all the predisposing factors and their complex interrelationship with each other. This model is ideally suited to study chronic disease. The web of causation does not imply that the disease is controlled only when all the multiple chains of causation are removed.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/psm-pyq-11.jpg\" alt=\"\" width=\"700\" height=\"601\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The sufficient component cause model illustrates how multiple factors contribute to disease causation, with some factors being necessary components in multiple causal pathways.</span></p>",
      "correct_choice_id": 44714,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24690,
      "choices": [
        {
          "id": 98721,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspergillus</span></p>"
        },
        {
          "id": 98722,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucor</span></p>"
        },
        {
          "id": 98723,
          "text": "<p><span style=\"font-size:12.0pt;\">Talaromyces</span></p>"
        },
        {
          "id": 98724,
          "text": "<p><span style=\"font-size:12.0pt;\">Blastomyces</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the organism in the given image. (INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125651.jpg\" alt=\"\" width=\"300\" height=\"212\"></span></p>",
      "unique_key": "Q1098940",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mucor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histopathological staining shows broad septate, hyaline hyphae with wide angle branching, which suggests that it is more likely Mucor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/untitled-1.jpg\" alt=\"\" width=\"1000\" height=\"1464\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspergillus:</strong> Aspergillus shows aseptate narrow hyphae with acute angle branching.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Talaromyces:</strong> Talaromyces is a genus of fungi that forms septate hyphae and conidiophores.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Blastomyces:</strong> Blastomyces dermatitidis is a dimorphic fungus that appears as broad-based budding yeast in tissue sections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mucor is identified by broad aseptate hyaline hyphae with wide-angle branching, and it typically lacks rhizoids, unlike Rhizopus which has nodal rhizoids.</span></p>",
      "correct_choice_id": 98722,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4199,
      "choices": [
        {
          "id": 16775,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 16776,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
        },
        {
          "id": 16777,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 4</span></span></span></p>"
        },
        {
          "id": 16778,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaccination against which of the following is recommended in the elderly? (INICET MAY 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varicella zoster virus</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rotavirus</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Measles</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pneumococcal meningitis</span></span></span></li>\r\n</ol>",
      "unique_key": "Q8448861",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250993,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 1, 4</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The vaccination recommendations for the elderly typically include vaccines for Varicella Zoster Virus (to prevent shingles) and Pneumococcal meningitis (to prevent pneumococcal diseases, including meningitis).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Varicella Zoster Virus (VZV)</span></strong><span style=\"font-size:12.0pt\">: The recombinant zoster vaccine (RZV) is recommended for adults 50 years and older to prevent shingles and its complications.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pneumococcal meningitis</span></strong><span style=\"font-size:12.0pt\">: The pneumococcal vaccines (PCV13 and PPSV23) are recommended for adults 65 years and older to protect against pneumococcal diseases, including meningitis and pneumonia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/23/untitled-198.jpg\" style=\"height:572px; width:900px\" /></span></strong></span></span></p>",
      "correct_choice_id": 16777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9906,
      "choices": [
        {
          "id": 39590,
          "text": "<p><span style=\"font-size:12pt;\">1, 2</span></p>"
        },
        {
          "id": 39591,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 39592,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 39593,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which diagnostic investigation is utilized to identify the condition characterized by a 40-year-old man displaying abrupt erythematous painful lesions on the trunk and face, joint pain, and glove and stock anesthesia? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET May 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Nerve examination</span></li><li><span style=\"font-size:12pt;\">Skin biopsy</span></li><li><span style=\"font-size:12pt;\">Slit skin smear</span></li><li><span style=\"font-size:12pt;\">Mantoux test</span></li></ol>",
      "unique_key": "Q1377135",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250557,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical scenario points to a case of <strong>leprosy</strong>. The diagnosis of this condition requires <strong>nerve</strong> <strong>examination, skin biopsy, and a slit skin smear</strong> (option B - 1, 2, 3).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical presentation described suggests a condition called <strong>leprosy</strong> or <strong>Hansen's</strong> disease, which can cause <strong>skin</strong> <strong>lesions</strong>, <strong>nerve</strong> damage resulting in <strong>anaesthesia</strong>, and <strong>joint</strong> <strong>pain</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Nerve examination:</strong> An essential part of the diagnosis of leprosy involves the <strong>examination</strong> of <strong>nerves</strong> for <strong>enlargement</strong> and <strong>tenderness</strong>, which can indicate <strong>nerve</strong> <strong>damage</strong> due to the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Skin biopsy:</strong> A biopsy of the affected skin can be taken and <strong>histologically</strong> examined for the presence of <strong>Mycobacterium</strong> <strong>leprae</strong>, the bacterium that causes leprosy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Slit skin smear:&nbsp;</strong> This test involves taking a sample from the skin (usually from the <strong>earlobes</strong> or from lesions) and staining it for <strong>acid</strong>-<strong>fast</strong> <strong>bacilli</strong>, which is a characteristic of Mycobacterium leprae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Mantoux test:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The <strong>Mantoux</strong> test is used to diagnose <strong>tuberculosis</strong>, not leprosy.</span></li><li><span style=\"font-size:12pt;\">It involves the <strong>tuberculin</strong> <strong>skin</strong> <strong>test</strong> (<strong>TST</strong>) to detect Mycobacterium <strong>tuberculosis</strong> infection.</span></li><li><span style=\"font-size:12pt;\">Mycobacterium tuberculosis and Mycobacterium leprae are <strong>both</strong> <strong>acid</strong>-<strong>fast</strong> bacilli.</span></li><li><span style=\"font-size:12pt;\">The Mantoux test is <strong>specific</strong> for <strong>TB</strong> and does <strong>not</strong> directly <strong>aid</strong> in the <strong>diagnosis</strong> of <strong>leprosy</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Characteristic clinical features of Hansens disease / Leprosy</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mycobacterium leprae is the cause of the chronic granulomatous disease known as leprosy</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>The typical incubation period for leprosy is 2 to 12 years.</strong></span></li><li><span style=\"font-size:12pt;\">It frequently manifests as a <strong>visible skin</strong> lesion, such as a <strong>hypopigmented</strong> or <strong>erythematous</strong> macule, or as a <strong>numb</strong> <strong>spot</strong> on the skin.</span></li><li><span style=\"font-size:12pt;\">The <strong>face, buttocks, trunk, and extensor aspects</strong> of the limbs are frequently affected by lesions.</span></li><li><span style=\"font-size:12pt;\"><strong>Skin, cutaneous, and peripheral nerves</strong>, as well as <strong>mucous</strong> membranes, are all impacted.</span></li><li><span style=\"font-size:12pt;\">The <strong>posterior tibial nerve</strong>, followed by the ulnar, median, and lateral popliteal nerves, are the peripheral nerves that are most frequently affected.</span></li><li><span style=\"font-size:12pt;\"><strong>The facial nerve is the cranial nerve that is involved most frequently.</strong></span></li><li><span style=\"font-size:12pt;\">Both <strong>nerve function</strong> and <strong>hair growth</strong> are compromised by the lesions.</span></li><li><span style=\"font-size:12pt;\"><strong>Burns or ulcers on the amputation limb may also be present in the patients.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Classification systems of leprosy:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ridley-Jopling classification</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Tuberculoid (TT)</span></li><li><span style=\"font-size:12pt;\">Borderline tubercular (BT)</span></li><li><span style=\"font-size:12pt;\">Borderline (BB)</span></li><li><span style=\"font-size:12pt;\">Borderline lepromatous (BL)</span></li><li><span style=\"font-size:12pt;\">Lepromatous (LL)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>WHO classification:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Paucibacillary</span></li><li><span style=\"font-size:12pt;\">Multibacillary</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Cardinal signs for the diagnosis of leprosy:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-21-190935.png\" alt=\"\" width=\"1000\" height=\"292\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The presence of two of the three signs can establish the diagnosis of leprosy. Other tests done for diagnosis of leprosy include <strong>nerve biopsy in pure neural leprosy and PGL-1 antibody in cases with low bacterial load</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Mantoux test is not useful in diagnosis of leprosy</strong>. This is the test which helps to explain the <strong>prognosis o</strong>f leprosy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The appropriate diagnostic investigations for a suspected case of leprosy include <strong>nerve</strong> examination, skin <strong>biopsy</strong>, and <strong>slit</strong> <strong>skin</strong> <strong>smear</strong> to detect the presence of <strong>Mycobacterium</strong> <strong>leprae</strong> and to assess the extent of nerve damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 28 page no 28.1, 28.3, 28.12</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrisons principles of internal medicine, 21<sup>st</sup> edition 1385, 1386, 1388</strong></span></p>",
      "correct_choice_id": 39591,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3939,
      "choices": [
        {
          "id": 15735,
          "text": "<p><span style=\"font-size:12.0pt;\">Fasciola hepatica are seen in the intrahepatic biliary radicles</span></p>"
        },
        {
          "id": 15736,
          "text": "<p><span style=\"font-size:12.0pt;\">Schistosoma are monoecious</span></p>"
        },
        {
          "id": 15737,
          "text": "<p><span style=\"font-size:12.0pt;\">Fasciola hepatica acquired through contaminated water</span></p>"
        },
        {
          "id": 15738,
          "text": "<p><span style=\"font-size:12.0pt;\">Triclabendazole is the treatment of choice for all trematode infections</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statement is True regarding trematodes? (INICET MAY 2021)</span></p>",
      "unique_key": "Q3119113",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250992,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Fasciola hepatica are seen in the intrahepatic biliary radicles</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Of the given statements regarding trematodes, the only true statement is that Fasciola hepatica is seen in the intrahepatic biliary radicles</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fasciola hepatica is the largest and most common liver fluke found in man</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Habitat - The parasite resides in the liver and biliary passages of the definitive host.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Definitive host: <strong>Sheep, goat, cattle and man.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intermediate host: Snails</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mode of infection: The definitive host, sheep and man, get infection by <strong>ingestion of metacercariae encysted on aquatic vegetation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Life cycle-</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/23/untitled-192.jpg\" alt=\"\" width=\"500\" height=\"471\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Unlike other trematodes and basically all other flatworms, the <strong>schistosomes are dioecious, i.e., the sexes are separate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Schistosoma  Cercariae penetrates through skin, eggs with terminal spine, only snails as intermediate hosts and separate sexes.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Praziquantel remains the drug of choice for all trematode infections except fascioliasis</strong>, for which triclabendazole is the drug of choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Schistosoma are monoecious</strong>: This statement is false. Schistosomes are dioecious, meaning they have separate sexes (male and female), which is an exception among trematodes, as most are hermaphroditic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Fasciola hepatica acquired through contaminated water</strong>: This statement is false. Fasciola hepatica infection is acquired by ingestion of metacercariae encysted on aquatic vegetation, not directly through contaminated water.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Triclabendazole is the treatment of choice for all trematode infections</strong>: This statement is false. While triclabendazole is the drug of choice for fascioliasis, praziquantel remains the drug of choice for most other trematode infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fasciola hepatica is found in the intrahepatic biliary radicles of its definitive host. It is acquired through ingestion of metacercariae on aquatic vegetation, and its treatment of choice is triclabendazole. Schistosomes, unlike other trematodes, are dioecious, meaning they have separate sexes.</span></p>",
      "correct_choice_id": 15735,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4201,
      "choices": [
        {
          "id": 16783,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 16784,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 16785,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 16786,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are the objective tests for the hearing? (</span>INICET May 2021)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">BERA (Brainstem evoked response audiometry)</span></li><li><span style=\"font-size:12.0pt;\">OAE (Otoacoustic emission)</span></li><li><span style=\"font-size:12.0pt;\">PTA (Pure tone audiometry)</span></li><li><span style=\"font-size:12.0pt;\">Tympanometry</span></li></ol>",
      "unique_key": "Q2266806",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250504,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 1, 2 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Objective tests for hearing do not require the active cooperation or response from the patient and are thus particularly useful in non-cooperative subjects such as young children or those who might simulate hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. BERA</strong> - Also called BAER or BAEP (brainstem auditory evoked response or potential) is an objective test to elicit brainstem responses to auditory stimulation by clicks or tone bursts. It is a noninvasive technique to find the integrity of central auditory pathways through the VIII<sup>th </sup>nerve, pons and midbrain</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. OAE</strong> is an objective test that records the low-intensity sounds produced by outer hair cells of a normal cochlea and can be elicited by a very sensitive microphone placed in the external ear canal and analyzed by a computer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Tympanometry</strong> is an objective test for compliance or stiffness of the tympano-ossicular system. It evaluates the mobility of the eardrum (tympanic membrane) and the conduction bones of the middle ear, providing useful information about middle ear pressure and fluid presence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. PTA (pure tone audiometry):</strong> This is a subjective test as it relies on the patient's response to pure tone stimuli. It is not included as an objective test because it requires the patient's active participation to indicate when a sound is heard. Subjective tests such as PTA, tuning fork tests, and speech audiometry depend on patient interaction and are susceptible to voluntary or involuntary response errors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Objective hearing tests like BERA, OAE, and Tympanometry provide essential diagnostic information without the need for patient interaction, distinguishing them from subjective tests like Pure Tone Audiometry which rely on patient responses.</span></p>",
      "correct_choice_id": 16783,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34045,
      "choices": [
        {
          "id": 136015,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha neuron</span></p>"
        },
        {
          "id": 136016,
          "text": "<p><span style=\"font-size:12.0pt;\">Gamma neuron</span></p>"
        },
        {
          "id": 136017,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta neuron</span></p>"
        },
        {
          "id": 136018,
          "text": "<p><span style=\"font-size:12.0pt;\">Delta neuron</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The motor supply of the muscle spindle is which of the following?&nbsp;</span>(INICET NOVEMBER 2023)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/29/picture11_PUBfeb5.jpg\" alt=\"\" width=\"400\" height=\"256\"></span></p>",
      "unique_key": "Q8010591",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250573,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gamma neuron</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gamma motor neurons specifically innervate the intrafusal fibers within the muscle spindles, adjusting their tension and sensitivity to stretch, which is crucial for proper proprioceptive feedback.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Alpha () neuron:</strong> Alpha motor neurons innervate extrafusal muscle fibers, which are the main contractile units of the muscle, and are not involved in the direct control of muscle spindle sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Beta () neuron:</strong> A Beta neurons are sensory in nature, so they neither supply extrafusal nor intrafusal muscle fibers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Delta () neuron:</strong> Delta neurons are sensory neurons that transmit pain, temperature, and coarse touch sensations. They do not provide motor supply to muscle spindles or any other muscle fibers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gamma motor neurons (A gamma) specifically innervate the intrafusal fibers of muscle spindles, adjusting their tension and sensitivity to stretch, which is crucial for proper proprioceptive feedback.</span></p>",
      "correct_choice_id": 136016,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4333,
      "choices": [
        {
          "id": 17309,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of nasal polyps</span></p>"
        },
        {
          "id": 17310,
          "text": "<p><span style=\"font-size:12.0pt;\">Eosinophilic mucin without invasion</span></p>"
        },
        {
          "id": 17311,
          "text": "<p><span style=\"font-size:12.0pt;\">Characteristic CT findings</span></p>"
        },
        {
          "id": 17312,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive fungal culture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are major diagnostic criteria for allergic fungal sinusitis except? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q7016972",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250989,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Positive fungal culture</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A positive fungal culture is a minor diagnostic criterion for allergic fungal rhinosinusitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This classification was detailed by Bent and Kuhn, who established criteria based on their findings of several clinical features important for the diagnosis of AFRS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Presence of nasal polyps:&nbsp;</strong>Polyps are a common and significant finding in AFRS, often contributing to the blockage and symptoms of sinusitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Eosinophilic mucin:&nbsp;</strong>A hallmark of AFRS, this refers to thick, peanut butter-like mucin with eosinophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Characteristic CT findings:&nbsp;</strong>These include hyperdense areas within the sinuses, which are indicative of fungal involvement and mucin accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-22%20134220.jpg\" width=\"1267\" height=\"586\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bent and Kuhn described a diagnostic criterion for AFRS. They found 11 important clinical features, 5 of which were termed major criteria and the remaining 6 features as minor criteria. These criteria includes:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Scott Brown 8<sup>th</sup> edition, Volume 1, Page No. 1049</strong></span></p>",
      "correct_choice_id": 17312,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49027,
      "choices": [
        {
          "id": 195683,
          "text": "<p><span style=\"font-size:18px;\">UPT before DMPA</span></p>"
        },
        {
          "id": 195684,
          "text": "<p><span style=\"font-size:18px;\">Give DMPA</span></p>"
        },
        {
          "id": 195685,
          "text": "<p><span style=\"font-size:18px;\">Give DMPA with 7 days of barrier</span></p>"
        },
        {
          "id": 195686,
          "text": "<p><span style=\"font-size:18px;\">Wait till next period</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A 32-year-old woman with no significant medical history, who has been using depot medroxyprogesterone acetate (DMPA) for contraception, presents to the clinic after missing her scheduled injection by 14 days. She denies any sexual activity since her last injection. Her last menstrual period was 10 weeks ago, and she has no signs of pregnancy. What is the most appropriate recommendation for this patient regarding contraception? </strong><i><strong>[INICET NOV 2023]&nbsp;</strong></i></span></p>",
      "unique_key": "Q5575001",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250572,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Give DMPA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">As per the ministry of health and family welfare guidelines, ideally Inj DMPA (Antara) should be administered 3 monthly as shown in the table below:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Follow up of clients (coming on scheduled date for next injection i.e after 3 months</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1_UFQNIHz.png\" width=\"1024\" height=\"205\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Defaulter:&nbsp;A defaulter is a client who does not return for the next injection on the scheduled date; but comes for it within the grace period&nbsp;i.e. 2 weeks earlier and upto 4 weeks later from the scheduled date).</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/2_LOTjz82.png\" width=\"1023\" height=\"370\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Drop out:&nbsp;A&nbsp;dropout is a MPAclient who comes for the next injection after the grace period of 4 weeks is over and more than 4 months have passed since she took her last injection</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/3_nN8y3tH.png\" width=\"1023\" height=\"207\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">In the scenario mentioned above, the patient is a DEFAULTER and hence the Inj should be administered as she falls within the grace period</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. UPT before DMPA</strong>: This would be appropriate if the patient&nbsp;was a drop-out, i.e. if she had presented &gt; 4 weeks of the date that she had to come on.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Give DMPA with 7 days of barrier</strong>: This approach would be recommended if the injection was delayed beyond&nbsp;4 weeks.&nbsp;</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Option D. Wait till next period</strong>: This unnecessarily delays contraceptive protection and is not recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">When a patient misses her scheduled DMPA injection by up to&nbsp;30 days, the most appropriate recommendation is to administer DMPA directly without pregnancy testing.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">This is because Inj DMPA is known to cause a delayed return to fertlity.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">This ensures continuous contraceptive protection while following evidence-based guidelines that balance safety with practical clinical considerations.</span></p></li></ul>",
      "correct_choice_id": 195684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5933,
      "choices": [
        {
          "id": 23702,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 doses of 6 mg given 12 hours apart</span></span></span></p>"
        },
        {
          "id": 23703,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 doses of 12 mg given 24 hours apart</span></span></span></p>"
        },
        {
          "id": 23704,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4 doses of 6 mg given 12 hours apart</span></span></span></p>"
        },
        {
          "id": 23705,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4 doses of 12 mg given 12 hours apart</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the dose of dexamethasone given for fetal lung maturity?&nbsp;</span></span>(INICET MAY 2021)</p>",
      "unique_key": "Q6511157",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250999,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 4 doses of 6 mg given 12 hours apart</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For fetal lung maturity, dexamethasone is administered to help reduce the risks associated with premature birth by promoting the development of the fetal lungs. The recommended regimen for dexamethasone is:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4 doses of 6 mg each&nbsp;</span></strong><span style=\"font-size:12.0pt\">administered intramuscularly every <strong>12 hours</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This dosing schedule is intended to maximize the benefit of corticosteroids in promoting fetal lung maturity and reducing the incidence of complications associated with preterm birth, such as respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, and the need for ventilatory support.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 2 doses of 6 mg given 12 hours apart:</span></strong><span style=\"font-size:12.0pt\"> Incorrect. This dosing regimen is not the standard for dexamethasone. The correct regimen involves 4 doses of 6 mg.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. 2 doses of 12 mg given 24 hours apart:</span></strong><span style=\"font-size:12.0pt\"> Incorrect. This regimen is used for betamethasone, not dexamethasone. The standard for dexamethasone is 4 doses of 6 mg.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 4 doses of 12 mg given 12 hours apart:</span></strong><span style=\"font-size:12.0pt\"> Incorrect. The correct dosing for dexamethasone is 6 mg per dose, not 12 mg.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For fetal lung maturity, the recommended dose of dexamethasone is 4 doses of 6 mg given intramuscularly every 12 hours.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 2088, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23704,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54781,
      "choices": [
        {
          "id": 218589,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasma</span></p>"
        },
        {
          "id": 218590,
          "text": "<p><span style=\"font-size:12.0pt;\">Varicella</span></p>"
        },
        {
          "id": 218591,
          "text": "<p><span style=\"font-size:12.0pt;\">HSV</span></p>"
        },
        {
          "id": 218592,
          "text": "<p><span style=\"font-size:12.0pt;\">CMV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with a history of painful genital ulcers 1 year back has a neonate of 1 week who has lesions on face and body with neurological symptoms. What is the likely infection? (INICET MAY 2024)</span></p>",
      "unique_key": "Q2766841",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250503,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) HSV (Herpes Simplex Virus)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The question presents a scenario where a woman has a history of painful genital ulcers and has given birth to a neonate who now exhibits lesions on the face and body along with neurological symptoms. This clinical picture strongly suggests a neonatal herpes simplex virus (HSV) infection.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Herpes Simplex Virus (HSV)</strong> is known to cause painful genital ulcers in adults. The virus can remain latent in the body and reactivate later. During pregnancy or delivery, HSV can be transmitted to the neonate, particularly during vaginal delivery if there are active lesions or viral shedding. Neonatal HSV infection can present with vesicular lesions on the skin, eyes, and mouth, and it may also involve the central nervous system, leading to neurological symptoms. Neonatal HSV infection is a serious condition that requires prompt antiviral treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Toxoplasma:</strong> Incorrect because it does not cause painful genital ulcers in the mother or the described symptoms in the neonate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Varicella:</strong> Incorrect because, although it can cause skin lesions in neonates, it is not linked with a history of painful genital ulcers in the mother.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CMV:</strong> Incorrect because CMV can cause congenital infections with neurological symptoms, but it is not associated with painful genital ulcers in the mother.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A history of painful genital ulcers in the mother, especially when associated with neonatal lesions and neurological symptoms, is highly suggestive of neonatal HSV infection. HSV is a serious condition that requires immediate medical attention to prevent severe outcomes in the neonate.</span></p>",
      "correct_choice_id": 218591,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73226,
      "choices": [
        {
          "id": 291861,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Meissners corpuscles</span></p>"
        },
        {
          "id": 291862,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Merkel disk</span></p>"
        },
        {
          "id": 291863,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Pacinian corpuscles</span></p>"
        },
        {
          "id": 291864,
          "text": "<p><span style=\"font-size:16px;\">Ruffini ending&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is involved in Static Two-point discrimination? (INICET NOV 2024)</span></p>",
      "unique_key": "Q8960900",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250569,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Merkel disk</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Static two-point discrimination requires a receptor that <strong>adapts very slowly to maintain sensation over a prolonged period.</strong> Merkel cells are crucial for this function.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Merkel cells:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">They are <strong>slow-adapting receptors</strong></span></li><li><span style=\"font-size:16px;\"><strong>Excellent for 2-point discrimination</strong></span></li><li><span style=\"font-size:16px;\">Have a <strong>less</strong> receptive field</span></li><li><span style=\"font-size:16px;\">Critical for detecting <strong>edges and points</strong></span></li><li><span style=\"font-size:16px;\">Particularly important for tasks like <strong>Braille reading</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">The key characteristics that make Merkel cells ideal for static two-point discrimination are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Slow adaptation rate</span></li><li><span style=\"font-size:16px;\">Ability to detect <strong>steady stimuli</strong></span></li><li><span style=\"font-size:16px;\">Precise localization of sensory input</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Meissner's corpuscles</strong>: Incorrect. These are rapidly adapting receptors, making them unsuitable for static discrimination. They are best for fine touch sensations.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Pacinian corpuscles:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>These are rapidly adapting receptors present at Deep dermis, joint capsule that <strong>sense high-frequency vibration and pressure</strong>, not static stimuli.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Ruffini ending:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>While these are slow-adapting mechanoreceptors, they primarily sense <strong>stretch and sustained pressure,</strong> not precise point discrimination.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_bKoOXLC.png\" width=\"1039\" height=\"633\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_g0UtPCH.png\" width=\"1039\" height=\"374\"></strong></span></p>",
      "correct_choice_id": 291862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6005,
      "choices": [
        {
          "id": 23990,
          "text": "<p><span style=\"font-size:12pt;\">Immunosuppression can be continued during pregnancy</span></p>"
        },
        {
          "id": 23991,
          "text": "<p><span style=\"font-size:12pt;\">Pregnancy to be planned once the disease has been quiescent for at least 6 months and there is no evidence of renal dysfunction</span></p>"
        },
        {
          "id": 23992,
          "text": "<p><span style=\"font-size:12pt;\">High dose corticosteroids for lupus flare in pregnancy is safe</span></p>"
        },
        {
          "id": 23993,
          "text": "<p><span style=\"font-size:12pt;\">Ecospirin, methotrexate, cyclophosphamide, corticosteroids, azathioprine are safe in pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is not true about lupus nephritis in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q3092800",
      "question_audio": null,
      "question_video": null,
      "map_id": 23251042,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Ecospirin, methotrexate, cyclophosphamide, corticosteroids, azathioprine are safe in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">SLE is a chronic autoimmune disorder involving the multisystem. It affects young women of childbearing age. The renal involvement of the disease can manifest in the form of active lupus nephritis or flare-ups during pregnancy.</span></li><li><span style=\"font-size:12pt;\">It can lead to preterm births, preeclampsia, and pregnancy loss while the infant can suffer from neonatal lupus and heart block.</span></li><li><span style=\"font-size:12pt;\">Management includes</span></li><li><span style=\"font-size:12pt;\">Preconceptionally counseling: Conception during a period of quiescence for at least 6 months determines a successful outcome. Stable remission of renal disease for at least 6 months before conception is recommended.</span></li><li><span style=\"font-size:12pt;\">Corticosteroids are useful during episodes of lupus flare and can be used safely in pregnancy.</span></li><li><span style=\"font-size:12pt;\">Immunosuppressants such as azathioprine can be continued during pregnancy. It may be used in case of severe SLE</span></li><li><span style=\"font-size:12pt;\">Hydroxychloroquine is found to be the best for maintenance and is safe in pregnancy. It can prevent the need for prolonged corticosteroid therapy.</span></li><li><span style=\"font-size:12pt;\">Methotrexate and cyclophosphamide are teratogenic and hence they are not safe during pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Immunosuppression can be continued during pregnancy</strong>: Correct. Medications like azathioprine can be continued under medical guidance, while others are used cautiously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Pregnancy to be planned once the disease has been quiescent for at least 6 months and there is no evidence of renal dysfunction</strong>: Correct. Quiescence of the disease and stable renal function are crucial for a successful pregnancy outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. High dose corticosteroids for lupus flare in pregnancy is safe</strong>: Correct. High doses of corticosteroids can be used during a lupus flare, but must be carefully monitored.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Methotrexate and cyclophosphamide are not safe during pregnancy for managing lupus nephritis; corticosteroids and azathioprine are safer options.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 2895, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13923,
      "choices": [
        {
          "id": 55653,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        },
        {
          "id": 55654,
          "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
        },
        {
          "id": 55655,
          "text": "<p><span style=\"font-size:12.0pt;\">C</span></p>"
        },
        {
          "id": 55656,
          "text": "<p><span style=\"font-size:12.0pt;\">D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with right-sided loss of sensations of both the upper and lower limb complains of shooting pain from her fingers to the right shoulder and a burning sensation when touching cold water. Motor functions are normal. Which of the following structures is likely to be involved? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET May 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-71_2KvCA3I.jpg\" alt=\"\" width=\"300\" height=\"196\"></span></p><p style=\"text-align:justify;\">&nbsp;</p>",
      "unique_key": "Q1848788",
      "question_audio": null,
      "question_video": null,
      "map_id": 23251041,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Thalamus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical stem of a hemi-sensory loss and severe excruciating pain of the affected areas is suggestive of thalamic pain syndrome also known as Dejerine Roussy syndrome. Hence, thalamus marked as B is most likely to be involved.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The thalamus is a paired structure, with one thalamus on each side of the brain. It relays sensory and motor signals to the cerebral cortex and regulates consciousness, sleep, and alertness. The thalamus has multiple nuclei, each serving different functions. The ventral posterior nucleus, for instance, is vital for relaying somatosensory information. If the thalamus is damaged, it can lead to loss of sensation, and in certain cases, even cause the burning, shooting pain and abnormal temperature sensations described in the scenario, which aligns with the symptoms of thalamic syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture2_rw0NybC.jpg\" alt=\"\" width=\"600\" height=\"304\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The structures marked in the image are:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp; </strong>A- Internal capsule</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. B- Thalamus</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> C- Subthalamic nucleus</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> D- Substantia nigra</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lesion in other three structures will lead to motor deficit and in question it is clearly mentioned that there is no motor deficit, only sensory deficit is the which &nbsp;clearly indicates that the lesion lies in thalamus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Internal capsule</strong>: The internal capsule is a bundle of white matter fibers that separates the caudate nucleus and the thalamus from the lenticular nucleus (putamen and globus pallidus). The anterior limb separates the head of the caudate from the lenticular nucleus, while the posterior limb separates the thalamus from the lenticular nucleus. It contains ascending and descending axonal fibers running between the cerebral cortex and the brainstem/spinal cord. Damage to the internal capsule, especially its posterior limb, can cause contralateral hemiparesis or hemiplegia (motor deficits). However, the woman's motor functions are described as normal, making this a less likely option given the scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Subthalamic nucleus</strong>: The subthalamic nucleus is part of the basal ganglia circuit and is specifically associated with motor function. Lesions of the subthalamic nucleus, particularly on one side, might result in hemiballismus, which is characterized by violent, flinging movements of the contralateral limbs. It is not typically associated with sensory disturbances, or the pain described in the scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Substantia nigra</strong>: The substantia nigra is in the midbrain and plays a critical role in reward, addiction, and movement. It contains dopamine-producing neurons. The degeneration of these neurons is a hallmark of Parkinson's disease. Lesions in the substantia nigra would primarily produce motor symptoms, such as rigidity, bradykinesia, and tremors. It would not typically lead to the sensory disturbances described in the scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>The thalamic pain syndrome</strong> is caused by the occlusion of these thalamic and thalamogeniculate branches. C/L hemisensory loss, which begins as numbness and escalates to cause intense burning pain in the affected areas, is what distinguishes it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A thalamic lesion results in a breakdown in communication between the brain's afferent route and cortex because the thalamus serves as the site for the relay of sensory information between the periphery and cortex. The healing process following a thalamic infarct is painful.</span></p>",
      "correct_choice_id": 55654,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10076,
      "choices": [
        {
          "id": 40270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Necrosis</span></span></span></p>"
        },
        {
          "id": 40271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Apoptosis</span></span></span></p>"
        },
        {
          "id": 40272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Necroptosis</span></span></span></p>"
        },
        {
          "id": 40273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Entosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"margin-right:-64px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In which of the following phenomenon, Cell in cell appearance is seen?</span> <span style=\"font-size:12.0pt\">(INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q9580488",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250998,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Entosis</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cell in cell appearance is seen in Entosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Entosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a form of cell death that occurs when one cell inserts itself into the neighboring cell, which results in the ultimate death of the invading cell. This creates a characteristic cell-in-cell (CIC. pattern. It plays a physiological role in the elimination of cells detached from a surface.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NOTE: Emperipolesis vs Entosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Emperipolesis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a cellular process in which one cell enters into another cell without being degraded or destroyed. This process occurs in various cell types, including immune cells and cancer cells, and is thought to play a role in cell-to-cell communication and immune surveillance. In emperipolesis, the engulfed cell remains intact and is usually released from the host cell after a certain period of time.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture7_t5T5RZb.jpg\" style=\"height:274px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Entosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> on the other hand, is a cellular process in which one cell actively engulfs and digests another cell. This process occurs primarily in epithelial cells and is thought to play a role in tissue homeostasis and elimination of damaged or excess cells. In entosis, the engulfed cell is degraded and digested by the host cell&#39;s lysosomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In summary, the main difference between emperipolesis and entosis is that in emperipolesis, the engulfed cell remains intact and is usually released from the host cell, while in entosis, the engulfed cell is degraded and digested by the host cell.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Necrosis</span></strong><span style=\"font-size:12.0pt\">: Necrosis is a form of cell death characterized by uncontrolled cellular breakdown due to injury or disease. It does not involve a cell-in-cell appearance and is marked by cell swelling, membrane rupture, and inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Apoptosis</span></strong><span style=\"font-size:12.0pt\">: Apoptosis is a form of programmed cell death involving cell shrinkage, chromatin condensation, and the formation of apoptotic bodies, but it does not result in a cell-in-cell appearance. Instead, apoptotic cells are typically engulfed and removed by phagocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Necroptosis</span></strong><span style=\"font-size:12.0pt\">: Necroptosis is a regulated form of necrosis or inflammatory cell death that is triggered by certain death receptors. Like necrosis, it does not involve a cell-in-cell appearance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The cell-in-cell appearance is characteristic of <strong>entosis</strong>, where one cell engulfs and digests another, distinguishing it from other forms of cell death.</span></span></span></p>",
      "correct_choice_id": 40273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9927,
      "choices": [
        {
          "id": 39674,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 5</span></p>"
        },
        {
          "id": 39675,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 39676,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 5</span></p>"
        },
        {
          "id": 39677,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which mediators involved in the early phase of type 1 hypersensitivity?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Mast cell</span></li><li><span style=\"font-size:12.0pt;\">Histamine</span></li><li><span style=\"font-size:12.0pt;\">Neutrophils</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandins</span></li><li><span style=\"font-size:12.0pt;\">Leukotrienes</span></li></ol>",
      "unique_key": "Q7229439",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250991,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2, 4, 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type 1 hypersensitivity</strong> reactions, also known as immediate hypersensitivity reactions, are typically triggered by allergens and involve the rapid release of mediators from mast cells. The <strong>early phase</strong> of type 1 hypersensitivity involves several key mediators:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mast cells (1)</strong>: Play a central role in initiating the reaction. When IgE antibodies on the surface of mast cells bind to an allergen, the mast cells degranulate, releasing various mediators.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Histamine (2)</strong>: One of the primary mediators released from mast cells, responsible for many of the acute symptoms of allergic reactions, such as vasodilation, increased vascular permeability, and smooth muscle contraction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prostaglandins (4)</strong>: Specifically, <strong>Prostaglandin D2 (PGD2)</strong>, is produced by mast cells and contributes to vasodilation, bronchoconstriction, and increased mucus secretion.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Leukotrienes (5)</strong>: Specifically, <strong>Leukotrienes C4 and D4</strong> are potent mediators that cause prolonged bronchoconstriction, increased vascular permeability, and mucus production.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Neutrophils (3)</strong>, while involved in various immune responses, are not typically considered mediators of the early phase of type 1 hypersensitivity. They are more associated with later phases of inflammation or other types of immune responses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Early phase&nbsp;</strong>of type 1 hypersensitivity involves Mast cells, Histamine, Prostaglandins (D2) and Leukotrienes (C4 and D4).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-174004.jpg\" alt=\"\" width=\"1000\" height=\"287\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 377</strong></span></p>",
      "correct_choice_id": 39676,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24699,
      "choices": [
        {
          "id": 98757,
          "text": "<p><span style=\"font-size:12.0pt;\">Maydl's hernia</span></p>"
        },
        {
          "id": 98758,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduction en masse</span></p>"
        },
        {
          "id": 98759,
          "text": "<p><span style=\"font-size:12.0pt;\">Sliding hernia</span></p>"
        },
        {
          "id": 98760,
          "text": "<p><span style=\"font-size:12.0pt;\">Incarcerated hernia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A surgeon returns the entire hernial sac into the abdominal cavity of a patient with an inguinal hernia without reducing its contents. What is this known as? </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
      "unique_key": "Q7185449",
      "question_audio": null,
      "question_video": null,
      "map_id": 23251040,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Reduction en masse</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When the surgeon returns the entire hernial sac to the abdominal cavity without reducing its contents, this procedure is known as \"reduction en masse\" of the hernia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Reduction en-masse of inguinal hernia means reduction/migration of a hernial sac along with the incarcerated bowel into the peritoneal cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Maydl's</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>hernia</strong>: Double loop of intestine is within a hernia sac with a tight neck.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/hernia-13.jpg\" alt=\"\" width=\"400\" height=\"315\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sliding hernia</strong>: Organs like cecum (right) and sigmoid (left) accompany the sac and are present outside the sac.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/hernia-11.jpg\" alt=\"\" width=\"400\" height=\"295\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Incarcerated hernia</strong>: An incarcerated hernia is&nbsp;a part of the intestine or abdominal tissue that becomes trapped in the sac of a hernia (irreducible).</span></p>",
      "correct_choice_id": 98758,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7063,
      "choices": [
        {
          "id": 28220,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
        },
        {
          "id": 28221,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medulloblastoma</span></span></span></p>"
        },
        {
          "id": 28222,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pleuropulmonary blastoma</span></span></span></p>"
        },
        {
          "id": 28223,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hodgkin&#39;s lymphoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nivolumab is used as a checkpoint inhibitor in?</span></span></p>",
      "unique_key": "Q6758896",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250502,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Hodgkin&#39;s lymphoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab is a monoclonal antibody that works as an immune checkpoint inhibitor by blocking the interaction between PD-1 on the surface of T cell and its ligand present on the tumor cell. It is used in the treatment of Non-small cell lung cancer, Hodgkin&rsquo;s Lymphoma, Advanced melanoma and advanced head and neck cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>Retinoblastoma</strong>: Nivolumab is not typically used for the treatment of retinoblastoma, which is a rare type of eye cancer that usually develops in early childhood.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>Medulloblastoma</strong>: This is a type of brain cancer more common in children. Nivolumab is not a standard treatment for medulloblastoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">. <strong>Pleuropulmonary blastoma</strong>: This is a rare type of cancer that starts in the lung or pleural cavity, mostly affecting children. Nivolumab is not indicated for this cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab is an immune checkpoint inhibitor used for the treatment of Hodgkin&rsquo;s lymphoma, among other cancers such as non-small cell lung cancer, advanced melanoma, and advanced head and neck cancer. It works by blocking the PD-1/PD-L1 interaction, thereby enhancing the immune response against cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immune check point inhibitors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">N</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ew: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>N</strong>ivolumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">rugs: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>D</strong>urvalumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ct: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>A</strong>velumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>At</strong>ezolizumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">mmune: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>I</strong>pilimumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">heck: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>C</strong>emiplimab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">oint: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>P</strong>embrolizumab</span></span></span></p>",
      "correct_choice_id": 28223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10313,
      "choices": [
        {
          "id": 41218,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased indirect bilirubin, increased urobilinogen, absent bilirubin in urine</span></p>"
        },
        {
          "id": 41219,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased indirect bilirubin, absent urobilinogen, absent bilirubin in urine</span></p>"
        },
        {
          "id": 41220,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased direct bilirubin, increased urobilinogen, absent bilirubin in urine</span></p>"
        },
        {
          "id": 41221,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased direct bilirubin, absent urobilinogen, absent bilirubin in urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is seen in physiological jaundice? </span><span style=\"font-size:10.5pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2021)</span></p>",
      "unique_key": "Q3574255",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250510,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Increased indirect bilirubin, increased urobilinogen, absent bilirubin in urine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In physiological jaundice, there is increased indirect bilirubin, increased urobilinogen, absent bilirubin in urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Physiological jaundice occurs as a result of increased bilirubin production caused by foetal RB destruction, as well as a transient limitation in bilirubin conjugation in the immature neonatal liver. As a result, indirect/unconjugated bilirubin levels would rise. Increased levels of unconjugated bilirubin in the blood cause an increase in the production of urobilinogen, which is found in large quantities in the urine. Urine bilirubin is uncommon in this condition.</span></p><p>&nbsp;</p><p>Both physiological jaundice (indirect) and hepatocellular jaundice (direct) can have increased urobilinogen - just through different mechanisms:</p><ul><li>Physiological:  bilirubin load despite immature conjugation</li><li>Hepatocellular:  conjugated bilirubin reaching gut despite liver damage</li></ul><p><br>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-124435.png\" alt=\"\" width=\"1000\" height=\"524\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The following indications are suggestive of pathological jaundice and it warrants further investigations for the cause of jaundice.</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Jaundice appearing in the first 24-36 hours of birth</span></li><li><span style=\"font-size:12.0pt;\">A rise in serum bilirubin faster than 5mg/dl/24hr</span></li><li><span style=\"font-size:12.0pt;\">Serum bilirubin &gt; 12mg/dL in a full-term infant(especially if there are no risk factors)</span></li><li><span style=\"font-size:12.0pt;\">Serum bilirubin &gt; 10-14mg/dL in a preterm infant</span></li><li><span style=\"font-size:12.0pt;\">Persistent jaundice after 10-14 days of birth</span></li><li><span style=\"font-size:12.0pt;\">Direct bilirubin &gt; 2mg/dL at any time</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If there is persistent indirect hyperbilirubinemia for more than 2 weeks it indicates hemolysis, hereditary glucuronyl transferase deficiency, breastmilk jaundice, hypothyroidism, or intestinal obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When the concentration of unconjugated bilirubin exceeds 20-25mg/dL, bilirubin would penetrate the blood-brain barrier and lead to kernicterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phototherapy:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/24_pX9ChiD.jpg\" alt=\"\" width=\"500\" height=\"333\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Physiological jaundice is characterized by increased indirect bilirubin, increased urobilinogen, and the absence of bilirubin in the urine.</span></p>",
      "correct_choice_id": 41218,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11837,
      "choices": [
        {
          "id": 47314,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 and 5</span></span></p>"
        },
        {
          "id": 47315,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 and 5</span></span></p>"
        },
        {
          "id": 47316,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 2</span></span></p>"
        },
        {
          "id": 47317,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 only</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 62-year-old male patient with heart failure is scheduled for a heart transplant. His renal function test is deranged, and hemoglobin is 6 g/dL. The physician ordered 2 units of whole blood. Four hours after transfusion, he developed severe respiratory distress. On examination, he is hypoxemic, has tachycardia, and his mean arterial pressure is elevated. Which of the following are the best investigations for the above scenario? (INICET NOV 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chest X-ray</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brain natriuretic peptide (BNP) level</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Absolute neutrophil count</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leucocyte antibodies</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Platelets</span></span></span></li>\r\n</ol>",
      "unique_key": "Q6030204",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250558,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 1 and 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with signs and symptoms indicative of transfusion-associated circulatory overload (TACO), which includes elevated mean arterial pressure, hypoxemia, and respiratory distress following a blood transfusion. TACO occurs due to fluid overload from the transfusion, leading to pulmonary edema and increased cardiac filling pressures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Chest X-ray</span></strong><span style=\"font-size:12.0pt\">: This imaging is crucial as it can reveal bilateral infiltrates indicative of pulmonary edema, a hallmark of TACO. It helps to differentiate between TACO and other causes of respiratory distress post-transfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Brain Natriuretic Peptide (BNP) Level</span></strong><span style=\"font-size:12.0pt\">: BNP is a cardiac biomarker that is elevated in conditions of increased cardiac pressure and volume overload, such as TACO. Elevated BNP levels would support the diagnosis of TACO, whereas BNP levels would not be elevated in transfusion-related acute lung injury (TRALI), another potential complication post-transfusion that presents with respiratory distress but usually with hypotension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. </span></strong><span style=\"font-size:12.0pt\"><strong>Absolute neutrophil count </strong>and <strong>5.</strong> <strong>platelets </strong>are not specific for diagnosing TACO or TRALI. These parameters do not provide information on fluid overload or cardiac stress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. </span></strong><span style=\"font-size:12.0pt\"><strong>Leucocyte antibodies </strong>are not directly relevant to the diagnosis of TACO. Leucocyte antibodies might be involved in TRALI, but not TACO.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with suspected transfusion-associated circulatory overload (TACO), the best investigations are a chest X-ray to detect pulmonary edema and BNP levels to assess cardiac stress and fluid overload</span></span></span></p>",
      "correct_choice_id": 47316,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9949,
      "choices": [
        {
          "id": 39762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Graft versus host disease</span></span></span></p>"
        },
        {
          "id": 39763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HLA Alloimmunization</span></span></span></p>"
        },
        {
          "id": 39764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immunomodulation</span></span></span></p>"
        },
        {
          "id": 39765,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfusion Related Acute Lung Injury (TRALI)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transfusing irradiated red blood cells (RBCs) can effectively prevent which of the following conditions? (AIIMS MAY 2021) </span></span></p>",
      "unique_key": "Q9395616",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;A) Graft versus host disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transfusing irradiated red blood cells (RBCs) can effectively prevent <strong>transfusion-associated Graft-Versus-Host Disease (TA-GVHD)</strong>. TA-GVHD is a rare but serious complication that can occur when viable T lymphocytes present in the transfused blood product proliferate and attack the recipient&#39;s tissues. This is particularly dangerous in immunocompromised individuals or those receiving blood from close relatives where the donor lymphocytes are not recognized as foreign by the recipient&#39;s immune system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Irradiation of blood products helps to inactivate T lymphocytes, thereby preventing their proliferation and reducing the risk of TA-GVHD. This is crucial in certain patient populations, such as those undergoing bone marrow transplantation, those with congenital immunodeficiency disorders, and patients receiving blood from relatives.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. HLA alloimmunization</span></strong><span style=\"font-size:12.0pt\">: HLA alloimmunization refers to the development of antibodies against human leukocyte antigens (HLA) due to exposure to foreign antigens through transfusions or pregnancy. It is not specifically prevented by irradiating blood products.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Immunomodulation</span></strong><span style=\"font-size:12.0pt\">: Immunomodulation refers to the modulation of the immune response by transfused blood products, which is not specifically targeted by irradiation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transfusion-related acute lung injury (TRALI)</span></strong><span style=\"font-size:12.0pt\">: Transfusion-related acute lung injury (TRALI) is a rare but severe reaction that causes acute respiratory distress following transfusion. It is primarily caused by antibodies in the transfused blood reacting with the recipient&#39;s leukocytes, not by the presence of viable T lymphocytes, so irradiation does not prevent TRALI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The use of <strong>irradiated RBCs</strong> is specifically recommended to prevent <strong>Graft-Versus-Host Disease (GVHD)</strong>, making it the correct answer for this scenario.</span></span></span></p>",
      "correct_choice_id": 39762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9877,
      "choices": [
        {
          "id": 39474,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Pulmonary infarction</span></span></span></p>"
        },
        {
          "id": 39475,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Diffuse alveolar damage</span></span></span></p>"
        },
        {
          "id": 39476,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Endothelial injury</span></span></span></p>"
        },
        {
          "id": 39477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Fibrin clots</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common lung finding in COVID 19 infection is? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q3987471",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250565,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Diffuse alveolar damage</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Diffuse alveolar damage</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> may be seen in patients suffering from COVID-19.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">COVID-19 related histopathological changes in the lungs include:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Incipient pulmonary damage in early-stage disease with intraalveolar edema, endothelial necrosis, microthrombosis, and endothelialitis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Pneumocyte type 2 hyperplasia</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> in exudative phase</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Multiple intraalveolar giant cells in exudative phase</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hyaline membranes and solid fibrin deposits in exudative phase</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Thrombosis in small- to medium-sized vessels in early-stage lung disease</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Pulmonary infarction:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While pulmonary infarctions may occur due to thromboembolism, they are not the primary lung finding in COVID-19.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Endothelial injury:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Endothelial injury does occur in COVID-19 and contributes to microvascular damage and thrombosis, but it is part of the broader picture of diffuse alveolar damage.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Fibrin clots:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Fibrin clots are seen in COVID-19 as part of the coagulopathy associated with the disease, but they are secondary findings within the context of DAD.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diffuse alveolar damage&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is the most common and significant lung finding in severe COVID-19 infection, leading to the clinical syndrome of ARDS.</span></span></span></p>",
      "correct_choice_id": 39475,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11876,
      "choices": [
        {
          "id": 47470,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caf&eacute; au lait spot</span></span></p>"
        },
        {
          "id": 47471,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary thyroid carcinoma</span></span></p>"
        },
        {
          "id": 47472,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parathyroid adenoma</span></span></p>"
        },
        {
          "id": 47473,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Optic nerve glioma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is seen in MEN 2B syndrome? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q5603946",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250505,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Medullary thyroid carcinoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple Endocrine Neoplasia type 2B (MEN 2B) is a genetic syndrome characterized by the presence of specific tumors and physical features. This syndrome is often referred to as &quot;Triple M syndrome&quot; because it commonly presents with three key features: mucosal neuromas, a marfanoid body habitus, and medullary thyroid carcinoma. In addition, pheochromocytomas may also occur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medullary thyroid carcinoma (MTC) is a type of thyroid cancer originating from the parafollicular cells (C cells) that produce calcitonin. MTC is a hallmark of MEN 2B, making it one of the primary diagnostic criteria for the syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The condition is associated with mutations in the RET proto-oncogene, specifically the codon 918 mutation on chromosome 10, which leads to the development of these tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Caf&eacute; au lait spot:</span></strong><span style=\"font-size:12.0pt\"> Caf&eacute; au lait spots are not characteristic of MEN 2B syndrome. These pigmented skin lesions are more commonly associated with neurofibromatosis type 1 (NF1) and, in some cases, tuberous sclerosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Parathyroid adenoma:</span></strong><span style=\"font-size:12.0pt\"> Parathyroid adenomas are typically seen in patients with MEN 1 and MEN 2A syndromes, not in MEN 2B. These adenomas cause hyperparathyroidism, which is not a feature of MEN 2B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Optic nerve glioma:</span></strong><span style=\"font-size:12.0pt\"> Optic nerve gliomas are primarily associated with neurofibromatosis type 1 (NF1). They are not a feature of MEN 2B syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most significant feature of MEN 2B syndrome is the presence of medullary thyroid carcinoma, alongside mucosal neuromas and a marfanoid body habitus, often linked to mutations in the RET proto-oncogene</span></span></span></p>",
      "correct_choice_id": 47471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73694,
      "choices": [
        {
          "id": 293717,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin</span></p>"
        },
        {
          "id": 293718,
          "text": "<p><span style=\"font-size:12.0pt;\">Lamotrigine</span></p>"
        },
        {
          "id": 293719,
          "text": "<p><span style=\"font-size:12.0pt;\">Felbamate</span></p>"
        },
        {
          "id": 293720,
          "text": "<p><span style=\"font-size:12.0pt;\">Lacosamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which antiepileptic drug specifically enhances the inactivation phase of voltage-gated slow sodium channels, helping to stabilize hyperexcitable neurons?&nbsp;(INICET NOV 2024)</span></p>",
      "unique_key": "Q1206966",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250509,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Lacosamide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:16px;\">Lacosamide has a unique mechanism of action among antiepileptic drugs. It selectively enhances slow inactivation of voltage-gated sodium channels. While most sodium channel blocking antiepileptics (like phenytoin, carbamazepine) act on fast sodium channels, lacosamide specifically targets slow sodium channels. This mechanism helps stabilize hyperexcitable neuronal membranes and prevents repetitive neuronal firing.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\"><strong>Option A. Phenytoin</strong>: Incorrect. While it does act on sodium channels, it primarily blocks fast sodium channels, not slow sodium channels. It acts by promoting the inactive state of these channels.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Lamotrigine</strong>: Incorrect. Like phenytoin, it acts primarily on fast sodium channels and also affects calcium channels. It does not specifically target slow sodium channels.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Felbamate:</strong> Incorrect. It works primarily as an NMDA receptor antagonist and has no significant effect on sodium channels, either fast or slow.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">Lacosamide uniquely acts by enhancing the slow inactivation of voltage-gated sodium channels, distinguishing it from other sodium channel-blocking antiepileptics that act on fast sodium channels.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-08%20110456.jpg\" width=\"870\" height=\"522\"></span></p>",
      "correct_choice_id": 293720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54293,
      "choices": [
        {
          "id": 216641,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arthritis</span></span></span></p>"
        },
        {
          "id": 216642,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GI bleeding</span></span></span></p>"
        },
        {
          "id": 216643,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abdominal pain</span></span></span></p>"
        },
        {
          "id": 216644,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Skin rash</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following in IgA vasculitis warrants the use of corticosteroids?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7861595",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250506,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) GI bleeding</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IgA vasculitis, also known as Henoch-Sch&ouml;nlein purpura, typically presents with symptoms such as arthritis, abdominal pain, and skin rash. These symptoms are often managed with supportive care and nonsteroidal anti-inflammatory drugs (NSAIDs). However, the use of corticosteroids is reserved for more severe manifestations of the disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GI bleeding</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In cases where IgA vasculitis leads to gastrointestinal bleeding, corticosteroids are warranted. This is because GI bleeding indicates a severe form of the disease involving the gastrointestinal tract, which requires more aggressive treatment to reduce inflammation and prevent further complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Arthritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Joint pain and swelling associated with IgA vasculitis are usually mild and managed with NSAIDs or supportive care. Corticosteroids are not typically indicated for arthritis alone in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Abdominal pain</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Abdominal pain in IgA vasculitis can often be managed with supportive care and NSAIDs. Corticosteroids are reserved for severe cases or when there is evidence of significant gastrointestinal involvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Skin rash</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The characteristic purpuric rash of IgA vasculitis is usually self-limiting and does not require corticosteroids for treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids are indicated in IgA vasculitis primarily for severe manifestations such as gastrointestinal bleeding, indicating more extensive disease involvement.</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other manifestations, such as arthritis, abdominal pain, and skin rash, are generally self-limiting and respond well to supportive care. Corticosteroids are not typically required for these symptoms unless they are part of a more severe systemic involvement.</span></span></span></p>",
      "correct_choice_id": 216642,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54782,
      "choices": [
        {
          "id": 218593,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anomaly scan</span></span></p>"
        },
        {
          "id": 218594,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amniocentesis</span></span></p>"
        },
        {
          "id": 218595,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chorionic villous sampling</span></span></p>"
        },
        {
          "id": 218596,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NIPT</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient presents at 18 weeks with low risk of trisomy on quadruple marker and high risk of NTD. What is the next best step? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q4941181",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250568,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Anomaly scan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct answer is <strong>Anomaly scan</strong>. This patient has a low risk of trisomy (such as Down syndrome) but a high risk of neural tube defects (NTD) based on the quadruple marker test. The quadruple marker test includes measurements of beta-hCG, unconjugated estriol, inhibin A, and alpha-fetoprotein (AFP). A high level of AFP is associated with an increased risk of NTDs, such as spina bifida.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Given the elevated risk for NTDs, the most appropriate next step is an <strong>anomaly scan</strong>, specifically a targeted imaging for fetal anomaly (TIFA) scan. This ultrasound, typically performed between 18 and 20 weeks of gestation, has a high sensitivity (up to 99%) for detecting structural anomalies, particularly neural tube defects. The scan is a non-invasive way to assess the fetus for physical defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Amniocentesis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While amniocentesis can detect chromosomal abnormalities and some structural defects, it is invasive and carries a small risk of complications. Since the concern here is structural (NTD) rather than chromosomal, and the anomaly scan is highly effective and non-invasive, amniocentesis is not the first choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Chorionic villous sampling (CVS):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CVS is another invasive procedure used for early genetic testing, usually performed in the first trimester. It is not useful at 18 weeks and is not the best test for detecting structural anomalies like NTDs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. NIPT (Non-Invasive Prenatal Testing):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> NIPT is a screening tool for chromosomal aneuploidies (like trisomy 21, 18, and 13). Since the patient already has a low risk of trisomy, NIPT is unnecessary and does not address the high risk of NTD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a patient with a high risk of neural tube defects identified by elevated alpha-fetoprotein on a quadruple marker test, the best next step is an anomaly scan (TIFA), which is highly effective in identifying structural fetal abnormalities, including NTDs</span></span></span></p>",
      "correct_choice_id": 218593,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54256,
      "choices": [
        {
          "id": 216493,
          "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
        },
        {
          "id": 216494,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
        },
        {
          "id": 216495,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior MI</span></p>"
        },
        {
          "id": 216496,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Myocarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man presented with chest pain and shortness of breath. An ECG was taken in the emergency and was shown. What is the likely diagnosis?&nbsp;</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-101157.jpg\" alt=\"\" width=\"500\" height=\"234\"></span></p>",
      "unique_key": "Q7254253",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250567,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Posterior MI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's ECG shows classic signs of a posterior myocardial infarction (MI). The characteristic features of posterior MI in<strong> leads V1, V2 and () V3 include a</strong> <strong>tall R wave, ST depression, and upright T wave.</strong> These features suggest a mirror image of an infarction in the posterior wall of the left ventricle. While definitive diagnosis of a posterior MI typically involves additional leads (V7, V8, V9), the observed patterns in leads V2 and V3 are indicative of this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the provided case, the absence of ST elevation rules out an acute STEMI. NSTEMI and unstable angina can only be differentiated by cardiac biomarkers such as troponins, which are not mentioned here. Acute myocarditis would typically present with non-specific ECG changes and a relevant clinical history, such as a recent viral infection, which is not present in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. NSTEMI:</strong>&nbsp; NSTEMI (Non-ST Elevation Myocardial Infarction) can present with similar symptoms but requires positive cardiac troponins for diagnosis. The absence of troponin data makes this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Unstable Angina: </strong>Unstable angina presents with similar symptoms but without elevation of cardiac biomarkers. As mentioned, differentiating between NSTEMI and unstable angina is not possible without troponin levels, which are not provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acute Myocarditis:</strong> Acute myocarditis would typically present with a history of viral infection and can show non-specific ECG changes, often including sinus tachycardia. The patient's history and ECG findings do not support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of tall R waves, ST depression, and upright T waves in leads V2 and V3 are indicative of a posterior myocardial infarction.</span></p>",
      "correct_choice_id": 216495,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4284,
      "choices": [
        {
          "id": 17113,
          "text": "<p><span style=\"font-size:12.0pt;\">CD21</span></p>"
        },
        {
          "id": 17114,
          "text": "<p><span style=\"font-size:12.0pt;\">CD20</span></p>"
        },
        {
          "id": 17115,
          "text": "<p><span style=\"font-size:12.0pt;\">CD19</span></p>"
        },
        {
          "id": 17116,
          "text": "<p><span style=\"font-size:12.0pt;\">CD23</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The Epstein-Barr virus interacts with B cells via which of the following?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p>",
      "unique_key": "Q6810507",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250554,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) CD21</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Epstein-Barr virus (EBV) primarily infects B cells by binding to the CD21 receptor on the cell surface. CD21, also known as complement receptor 2 (CR2), is a receptor for the C3d fragment of the complement system and serves as the entry point for EBV into B cells. This interaction facilitates the virus's ability to infect and establish latency within B cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CD20</strong>: This is a protein expressed on the surface of all B cells and is involved in B cell activation and proliferation. It is not used by EBV for cell entry.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CD19</strong>: This is a surface protein that acts as a co-receptor in B cell receptor signaling, but it is not directly involved in EBV entry.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CD23</strong>: This is the low-affinity receptor for IgE and does not play a role in EBV infection of B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Epstein-Barr virus (EBV) infects B cells by binding to the CD21 receptor, which is the primary entry point for the virus into these cells.</span></li></ul>",
      "correct_choice_id": 17113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10493,
      "choices": [
        {
          "id": 41938,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dark areas represent necrosis, white areas represent viable liver tissue</span></span></span></p>"
        },
        {
          "id": 41939,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dark areas represent viable liver tissue, white areas represent necrosis</span></span></span></p>"
        },
        {
          "id": 41940,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">White areas represent central hepatocytes</span></span></span></p>"
        },
        {
          "id": 41941,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dark areas represent peri-portal hepatocytes</span><strong>&nbsp;</strong></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with cirrhosis and ascites presented to you. The gross appearance of his liver is as shown below. Which among the following is true about it? (AIIMS NOV 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-397.jpg\" style=\"height:202px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q9919889",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Dark areas represent necrosis; white areas represent viable liver tissue.</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The above picture shows centrilobular hemorrhagic necrosis. The cut liver section, in which major blood vessels are visible, is notable for a variegated, mottled, red appearance (nutmeg liver) seen in right heart failure. <strong>The dark areas represent necrosis; white areas represent viable liver tissue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nutmeg liver refers to the mottled appearance of the liver which resembles the cut section of nutmeg. This occurs as a result of hepatic venous congestion following right heart failure. The dark centrilobular zones reflect sinusoidal congestion<strong>. Congestion is seen around the central veins usually from right-sided heart failure. The pale periportal zones reflect normal or fatty liver tissue.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The liver derives its blood supply from the portal venous system and the hepatic artery. The portal triad constitutes:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Branches of the hepatic artery</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Portal vein</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bile duct</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The blood from the portal vein and the hepatic artery flow through the intervening sinusoids and drains into the central vein. The central veins from adjacent lobules form interlobular veins, which then unite as hepatic veins and finally drain into the inferior vena cava.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">The hepatic lobule is divided into three zones:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zone 1 is the periportal area</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zone 2 is the Intermediate zone</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zone 3 is the area closest to the central vein</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Right-sided cardiac failure leads to passive congestion of the liver</span></strong><span style=\"font-size:12.0pt\">. Left-sided cardiac failure leads to hypoperfusion and hypoxia of hepatocytes around central veins. The combination of hypoperfusion and retrograde congestion causes centrilobular hemorrhagic necrosis, leading to this mottled appearance of the liver, known as nutmeg liver.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Dark areas represent viable liver tissue, white areas represent necrosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is incorrect because the dark areas are where necrosis has occurred due to congestion, not viable tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. White areas represent central hepatocytes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The white areas represent periportal zones, which are generally healthier and not central hepatocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Dark areas represent peri-portal hepatocytes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The dark areas actually represent the centrilobular regions where necrosis has occurred, not the periportal hepatocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nutmeg liver&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is characterized by a mottled appearance, where <strong>dark areas represent necrosis</strong> due to chronic passive congestion, and <strong>white areas represent viable liver tissue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1665</span></strong></span></span></p>",
      "correct_choice_id": 41938,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16092,
      "choices": [
        {
          "id": 64328,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4</span></p>"
        },
        {
          "id": 64329,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3,4,2</span></p>"
        },
        {
          "id": 64330,
          "text": "<p><span style=\"font-size:12.0pt;\">1,4,3,2</span></p>"
        },
        {
          "id": 64331,
          "text": "<p><span style=\"font-size:12.0pt;\">4,3,2,1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the structures of the cubital fossa in sequence from medial to lateral? (</span>INICET Nov 2022)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Median nerve</span></p><p><span style=\"font-size:12.0pt;\">2. Radial nerve</span></p><p><span style=\"font-size:12.0pt;\">3. Tendon of biceps brachi</span></p><p><span style=\"font-size:12.0pt;\">4. Brachial artery</span></p>",
      "unique_key": "Q8022491",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250990,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 1,4,3,2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The structures are arranged in the cubital fossa from medial to lateral as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Median nerve</span></p><p><span style=\"font-size:12.0pt;\">2. Brachial artery</span></p><p><span style=\"font-size:12.0pt;\">3. Tendon of biceps brachii</span></p><p><span style=\"font-size:12.0pt;\">4. Radial nerve (Superficial Branch of radial nerve)</span></p><p><span style=\"font-size:12.0pt;\">Mnemonic is MBBR</span><br>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-13.jpg\" alt=\"\" width=\"500\" height=\"346\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cubital fossa is actually a triangular area located on the anterior aspect of the elbow, not the upper forearm. It is bounded by several structures, including:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The lateral border of the pronator teres muscle, which forms the medial boundary</span></li><li><span style=\"font-size:12.0pt;\">The medial border of the brachioradialis muscle, which forms the lateral boundary</span></li><li><span style=\"font-size:12.0pt;\">The imaginary line connecting the epicondyles of the humerus, which forms the superior boundary</span></li><li><span style=\"font-size:12.0pt;\">The floor of the cubital fossa is formed by the brachialis and supinator muscles, while the roof is formed by the Deep fascia of the skin.</span></li><li><span style=\"font-size:12.0pt;\">The roof of cubital fossa contains Subcutaneous veins which are used for routine phlebotomy procedures. These veins are - median cubital vein, cephalic vein and basilic vein</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cubital fossa contains several important structures, including the brachial artery, radial nerve, and median nerve. It is a common site for blood draws and intravenous catheter placement due to the relatively superficial location of the structures and ease of access.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-14.jpg\" alt=\"\" width=\"500\" height=\"365\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-15.jpg\" alt=\"\" width=\"500\" height=\"289\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:11pt;\">The correct anatomical sequencing of structures in the cubital fossa from medial to lateralmedian nerve, brachial artery, tendon of biceps brachii, and radial nerveis essential for both anatomical education and practical clinical applications.</span></p>",
      "correct_choice_id": 64330,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54844,
      "choices": [
        {
          "id": 218837,
          "text": "<p><span style=\"font-size:12.0pt;\">More risk of perianal fistulae</span></p>"
        },
        {
          "id": 218838,
          "text": "<p><span style=\"font-size:12.0pt;\">Lesions are continuous</span></p>"
        },
        {
          "id": 218839,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignancy is more common</span></p>"
        },
        {
          "id": 218840,
          "text": "<p><span style=\"font-size:12.0pt;\">Often presents with hematochezia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following findings is/are true about Crohns disease, in contrast to ulcerative colitis? (INICET MAY 2024)</span></p>",
      "unique_key": "Q5532962",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250500,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) More risk of perianal fistulae</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Crohn's disease and ulcerative colitis are both types of inflammatory bowel disease (IBD), but they have distinct characteristics and should not be considered the same. Crohn's disease can affect any part of the gastrointestinal tract, from the mouth to the anus, and is known for causing \"skip lesions,\" meaning areas of diseased tissue interspersed with healthy tissue.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Perianal fistulae</strong>: Crohns disease is more associated with perianal complications, including fistulae, abscesses, and fissures, due to the deeper transmural inflammation that characterizes the disease. This is in contrast to ulcerative colitis, which primarily involves the mucosa and submucosa and starts from the rectum, rarely involving perianal areas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lesions are continuous</strong>: This statement is incorrect for Crohns disease. Continuous lesions are characteristic of ulcerative colitis. In Crohns disease, the inflammation is patchy, with skip lesions being typical.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Malignancy is more common</strong>: Malignancy is more commonly associated with ulcerative colitis, particularly colorectal cancer, due to the long-standing inflammation typically confined to the colon. Crohns disease has a lower risk of malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Often presents with hematochezia</strong>: Hematochezia, or the passage of fresh blood in the stool, is more commonly associated with ulcerative colitis. Crohns disease typically presents with non-bloody diarrhea, although some cases might involve blood, it is not as frequent as in ulcerative colitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Crohns disease is characterized by a higher risk of perianal fistulae and skip lesions, in contrast to ulcerative colitis, which presents with continuous lesions and a higher risk of colorectal malignancy.</span></p>",
      "correct_choice_id": 218837,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54850,
      "choices": [
        {
          "id": 218861,
          "text": "<p><span style=\"font-size:12.0pt;\">Dissection of Beahrs triangle</span></p>"
        },
        {
          "id": 218862,
          "text": "<p><span style=\"font-size:12.0pt;\">Dissection of Zuckerkandl tubercle</span></p>"
        },
        {
          "id": 218863,
          "text": "<p><span style=\"font-size:12.0pt;\">Dissection of strap muscles</span></p>"
        },
        {
          "id": 218864,
          "text": "<p><span style=\"font-size:12.0pt;\">Ligation of Superior thyroid artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During total thyroidectomy for papillary thyroid cancer, which of the following steps will not lead to hoarseness of voice?&nbsp;</span></p>",
      "unique_key": "Q5489446",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250995,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Dissection of strap muscles</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hoarseness of voice after thyroidectomy is generally due to injury to the recurrent laryngeal nerve (RLN), which controls the vocal cords. The RLN is located near the thyroid gland, and careful surgical technique is necessary to avoid damaging it. The strap muscles, which are located anterior to the thyroid gland, are far from the path of the RLN, so dissecting these muscles will not result in hoarseness of voice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option &nbsp;A. Dissection of Beahrs triangle</strong>: The recurrent laryngeal nerve forms the anterior boundary of Beahrs triangle, making it susceptible to injury during dissection, which can lead to hoarseness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dissection of Zuckerkandl tubercle</strong>: The Zuckerkandl tubercle is closely associated with the recurrent laryngeal nerve, so dissection in this area can risk nerve injury and subsequent hoarseness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ligation of Superior thyroid artery</strong>: This procedure is generally more likely to affect the external branch of the superior laryngeal nerve rather than the recurrent laryngeal nerve, but in cases of anatomical variation, there is a small risk that the RLN could be affected, potentially leading to hoarseness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dissection of the strap muscles during thyroidectomy does not involve the recurrent laryngeal nerve, and therefore, will not cause hoarseness of voice.</span></p>",
      "correct_choice_id": 218863,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13150,
      "choices": [
        {
          "id": 52561,
          "text": "<p><span style=\"font-size:12.0pt;\">Rate of recurrence is 95%.</span></p>"
        },
        {
          "id": 52562,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a fibrovascular growth.</span></p>"
        },
        {
          "id": 52563,
          "text": "<p><span style=\"font-size:12.0pt;\">The parts of a pterygium are Body, head and cap</span></p>"
        },
        {
          "id": 52564,
          "text": "<p><span style=\"font-size:12.0pt;\">Has progressive and regressive types.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of pterygium? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5436835",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250996,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Rate of recurrence is 95%</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pterygium is a triangular fibrovascular ingrowth of degenerative conjunctival tissue.</span></li><li><span style=\"font-size:12.0pt;\">It is caused by prolonged exposure to UV rays, dry heat, etc.</span></li><li><span style=\"font-size:12.0pt;\">It has three parts: head (apical part on the cornea, body (region between limbus and canthus), and cap (semilunar white infiltrate in front of the head).</span></li><li><span style=\"font-size:12.0pt;\">Patients may experience itching and grittiness due to Dellen.</span></li><li><span style=\"font-size:12.0pt;\">It can interfere with vision and induce astigmatism.</span></li><li><span style=\"font-size:12.0pt;\">Stocker's line may be associated with pterygium, which is a linear deposition of iron seen in the corneal epithelium, anterior to the head of a pterygium.</span></li><li><span style=\"font-size:12.0pt;\">The recurrence rate after simple surgical excision is around 80%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture7_mN5l2bY.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pterygium is of 2 types:&nbsp;</span><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\">Progressive which is thick, fleshy, and vascular.</span></li><li><span style=\"font-size:12.0pt;\">Regressive which is thin, atrophic, and attenuated.</span></li></ol></li><li><span style=\"font-size:12.0pt;\">This condition can be treated symptomatically with tear substitutes for dry eye symptoms and patients are advised to avoid &nbsp;exposure to sun.</span></li><li><span style=\"font-size:12.0pt;\">Surgical excision with free conjunctival limbal autograft is the preferred treatment to avoid recurrence.</span></li><li><span style=\"font-size:12.0pt;\">The recurrence rate of pterygium is around 80% after simple surgical excision. Excision together with adjunctive therapies such as mitomycin C or 5-fluorouracil can reduce the risk of recurrence to approximately 10%.</span></li><li><span style=\"font-size:12.0pt;\">Reported Recurrence rate after P.E.R.F.E.C.T technique is 1.6% (Cornelius CR. Recurrence Rate and Complications of Pterygium Extended Removal Followed by Extended Conjunctival Transplant).</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-143100.png\" alt=\"\" width=\"1000\" height=\"977\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is a fibrovascular growth</strong>: This is accurate. Pterygium consists of fibrovascular tissue that can progressively invade the cornea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The parts of a pterygium are Body, head and cap</strong>: This is true. The pterygium is typically described as having three parts: the head (which is the part that extends onto the cornea), the body (the main bulk of the growth), and the cap or leading edge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Has progressive and regressive types</strong>: This is also true. Pterygium can be classified into progressive, which is active, vascular, and may encroach further onto the cornea, and regressive, which is typically less vascular and more fibrotic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pterygium's recurrence after surgical removal depends greatly on the surgical technique and the use of adjuvant therapies, not inherently 95% as previously thought. Effective management includes surgical excision combined with conjunctival autografts and adjuvant therapy to reduce the risk of recurrence significantly.</span></p>",
      "correct_choice_id": 52561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6017,
      "choices": [
        {
          "id": 24038,
          "text": "<p><span style=\"font-size:12pt;\">Growth of 10<sup>3</sup> coliform in suprapubic sample</span></p>"
        },
        {
          "id": 24039,
          "text": "<p><span style=\"font-size:12pt;\">Growth of 10<sup>5</sup> coliform in voided urine sample</span></p>"
        },
        {
          "id": 24040,
          "text": "<p><span style=\"font-size:12pt;\">Frequency with dysuria with &gt;3 WBC/HPF</span></p>"
        },
        {
          "id": 24041,
          "text": "<p><span style=\"font-size:12pt;\">Frequency with dysuria with positive nitrite and leucoesterase dipstick test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Urinary tract infection in a pregnant lady in her 2nd trimester is best defined as:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6065375",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250566,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Growth of 10<sup>5</sup> coliform in voided urine sample</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A urinary tract infection (UTI) in a pregnant woman is best defined by the growth of 10^5 coliforms per milliliter in a voided urine sample. This threshold is used to differentiate significant bacterial growth from contamination or a non-infectious presence of bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In pregnancy, the standard diagnostic method for UTI is a urine culture. A growth of 10^5 or more coliforms per milliliter in a properly collected voided urine sample is considered diagnostic for UTI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Growth of 103 coliform in suprapubic sample:</strong> Growth of 10^3 coliforms in a suprapubic sample is <strong>not a standard criterion</strong> for diagnosing UTI. Typically, suprapubic aspiration is used for more precise diagnoses, and lower thresholds may be acceptable due to reduced contamination risk compared to voided samples. However, for voided samples, the threshold is higher.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Frequency with dysuria with &gt;3 WBC/HPF:</strong> Frequency with dysuria and &gt;3 WBC/HPF indicates inflammation and <strong>possible infection</strong> but does not define a UTI by itself. The presence of WBCs in urine is a sign of inflammation or infection but is not specific for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Frequency with dysuria with positive nitrite and leucoesterase dipstick test:</strong> Frequency with dysuria and positive nitrite and leucocyte esterase dipstick tests <strong>suggest a UTI but are not definitive</strong>. These tests are helpful as preliminary screening tools but are not as definitive as a quantitative urine culture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A urinary tract infection in a pregnant lady in her 2nd trimester is best defined as the growth of 10^5 coliforms in a voided urine sample.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 348, DC Duttas Textbook of Obstetrics 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24039,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73662,
      "choices": [
        {
          "id": 293589,
          "text": "<p><span style=\"font-size:12.0pt;\">Yolk sac tumor</span></p>"
        },
        {
          "id": 293590,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysgerminoma</span></p>"
        },
        {
          "id": 293591,
          "text": "<p><span style=\"font-size:12.0pt;\">Choriocarcinoma</span></p>"
        },
        {
          "id": 293592,
          "text": "<p><span style=\"font-size:12.0pt;\">Granulosa cell tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is not classified as a germ cell tumor of the ovary? (INICET NOV 2024)</span></p>",
      "unique_key": "Q3883074",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Granulosa cell tumor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Granulosa cell tumor is a sex cord-stromal tumor, not a germ cell tumor of the ovary.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Granulosa cell tumors are derived from the sex cord-stromal cells of the ovary. These tumors are characterized by the presence of <strong>Call-Exner bodies and coffee bean-shaped nuclei</strong>. They are estrogen-secreting functional tumors that may present as <strong>precocious puberty, endometrial hyperplasia, or post-menopausal bleeding.</strong> The marker for granulosa cell tumors is <strong>Inhibin B,&nbsp;</strong>and they are associated with <strong>FOXL2 mutation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EEewVPf.png\" width=\"632\" height=\"452\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Yolk sac tumor: </strong>This is incorrect because yolk sac tumor, also known as <strong>endodermal sinus tumor,</strong> is a germ cell tumor of the ovary.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Yolk sac tumor (Endodermal sinus tumor)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">2nd MC malignant GCT</span></li><li><span style=\"font-size:16px;\">MC malignant ovarian tumor presenting in &lt;4years</span></li><li><span style=\"font-size:16px;\">Histology: presence of <strong>Schiller Duval Body/Glomeruloid body</strong></span></li><li><span style=\"font-size:16px;\">Tumor markers: AFP +,&nbsp;1 AT +ve</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_E90J34Y.png\" width=\"815\" height=\"472\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Dysgerminoma</strong>: This is incorrect because dysgerminoma is a germ cell tumor of the ovary. It is the ovarian counterpart of testicular seminoma.&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Ovarian counterpart of seminoma</span></li><li><span style=\"font-size:16px;\">MC malignant GCT</span></li><li><span style=\"font-size:16px;\">Radiosensitive, chemo-sensitive tumor</span></li><li><span style=\"font-size:16px;\">Unilateral involvement mostly (85%)</span></li><li><span style=\"font-size:16px;\">Non-Functional tumor: hormones not secreted</span></li><li><span style=\"font-size:16px;\">Markers include transcription factors (OCT 3/4, NANOG, KiT) and enzymes (PLAP +, LDH,  HCG but Normal AFP)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Choriocarcinoma:&nbsp;</strong>This is incorrect because&nbsp;<strong>choriocarcinoma</strong> can coexist with other <strong>germ cell tumors</strong>, as it can arise from either the <strong>ovary</strong> (germ cell origin) or the <strong>placenta</strong> (gestational trophoblastic disease)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">It secretes <strong>beta-hCG</strong>, which serves as a tumor marker.</span></li><li><span style=\"font-size:16px;\">If it has ovarian origin: non- responsive to&nbsp;chemotherapy  poor prognosis&nbsp;</span></li><li><span style=\"font-size:16px;\">If it has placenta origin excellent responsive to&nbsp;chemotherapy  good prognosis</span></li><li><span style=\"font-size:16px;\">Choriocarcinoma is known for early hematogenous spread and <strong>\"cannon-ball</strong>\" metastases to the lungs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Granulosa cell tumor is classified as a sex cord-stromal tumor of the ovary, not a germ cell tumor.</span></p>",
      "correct_choice_id": 293592,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2048,
      "choices": [
        {
          "id": 8185,
          "text": "<p><span style=\"font-size:12.0pt;\">B12</span></p>"
        },
        {
          "id": 8186,
          "text": "<p><span style=\"font-size:12.0pt;\">B6</span></p>"
        },
        {
          "id": 8187,
          "text": "<p><span style=\"font-size:12.0pt;\">Folate</span></p>"
        },
        {
          "id": 8188,
          "text": "<p><span style=\"font-size:12.0pt;\">Vit E</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Uracil was found in genetic code. Which vitamin deficiency leads to this condition:</span>(INICET May 2022)</p>",
      "unique_key": "Q6226926",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250508,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Folate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Folate deficiency is the correct answer. Folate (also known as vitamin B9) plays a crucial role in DNA synthesis and repair. When there is a deficiency in folate, it can lead to the misincorporation of Uracil into DNA, causing DNA instability and other genetic abnormalities.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. B12: </strong>A deficiency in vitamin B12 is not directly associated with the presence of Uracil in the genetic code. Vitamin B12 deficiency primarily affects red blood cell production and neurological functions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. B6: </strong>A deficiency in vitamin B6 is also not directly related to the presence of Uracil in the genetic code. Vitamin B6 deficiency can lead to various neurological symptoms but does not cause Uracil incorporation into DNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vit E: </strong>Vitamin E deficiency does not lead to the presence of Uracil in the genetic code. Vitamin E is primarily known for its antioxidant properties and its role in maintaining cell membranes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Genetic code is related to DNA, but DNA do not contain Uracil. In pyrimidine synthesis, UMP is the first pyrimidine nucleotide to be synthesized and other two pyrimidines thymine and Cytosine are synthesized from it. Uracil to cytosine conversion requires amino group addition provided by glutamine. Uracil is converted to thymine by enzyme thymidylate synthase by methylation where methyl group is donated by methyl-THF. So, a deficiency Folate will result in thymine deficiency and may lead to uracil appearing in the DNA in place of thymine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Harpers 31<sup>st</sup> ed/pg- 333</strong></span></p>",
      "correct_choice_id": 8187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14157,
      "choices": [
        {
          "id": 56589,
          "text": "<p><span style=\"font-size:12.0pt;\">From the tip of the nose to the ear lobule to the xiphisternum.</span></p>"
        },
        {
          "id": 56590,
          "text": "<p><span style=\"font-size:12.0pt;\">From the angle of the mouth to the tragus to the xiphisternum.</span></p>"
        },
        {
          "id": 56591,
          "text": "<p><span style=\"font-size:12.0pt;\">From the ala of the nose to the angle of the mandible to the xiphisternum.</span></p>"
        },
        {
          "id": 56592,
          "text": "<p><span style=\"font-size:12.0pt;\">From the angle of the mouth to the ear lobule to the umbilicus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the appropriate technique to measure the placement of a nasogastric tube? (INICET NOV 2021)</span></p>",
      "unique_key": "Q3463510",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250562,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) From the tip of the nose to the ear lobule to the xiphisternum.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct method. The nasogastric tube length is usually measured by estimating the distance from the tip of the nose, past the ear lobule (or the earlobe), and down to the xiphisternum (the point where the sternum meets the costal margin), also known as N-E-X rule. This method ensures that the tube is long enough to pass through the esophagus and reach the stomach without being too long to cause complications or too short to not be effective.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/whatsapp-image-2023-11-17-at-21320-pm.jpeg\" alt=\"\" width=\"300\" height=\"300\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To determine the appropriate length of a nasogastric tube (also known as Ryle's tube) used for treating intestinal obstruction or providing nutritional support, the NEX method is commonly used, which involves measuring from the tip of the nose to the ear lobule to the xiphisternum. The approximate length to be inserted is around 55 cm. The preferred position for inserting the Ryle's tube is in a sitting position with the neck slightly flexed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The proper positioning of the tube can be confirmed through auscultation in the epigastric area while injecting a bolus of air or by an abdominal radiograph. The ideal placement for an NG tube used for suction is within the stomach to avoid damage to the duodenum. In contrast, an NG feeding tube should be placed post-pyloric to reduce the risk of aspiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indications for NG tube usage include gastric decompression in intestinal obstruction, aspiration of gastric fluid, nutritional support, and medication administration. However, some absolute contraindications to NG tube insertion include severe midface trauma and recent nasal surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A tray of specialized instruments is used for nasogastric tube insertion, including a lubricating jelly, an NG tube, a syringe, and gloves, among others.</span></p>",
      "correct_choice_id": 56589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14155,
      "choices": [
        {
          "id": 56581,
          "text": "<p><span style=\"font-size:12.0pt;\">Transurethral resection of the bladder tumour</span></p>"
        },
        {
          "id": 56582,
          "text": "<p><span style=\"font-size:12.0pt;\">Resection with ileal conduit</span></p>"
        },
        {
          "id": 56583,
          "text": "<p><span style=\"font-size:12.0pt;\">Partial cystectomy with bladder reconstruction</span></p>"
        },
        {
          "id": 56584,
          "text": "<p><span style=\"font-size:12.0pt;\">Neo-adjuvant chemotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An adult male patient in his 60s presented to the outpatient department with a complaint of haematuria. Upon examination, a 2x2 cm bladder mass was observed, which was diagnosed as a low-grade transitional cell carcinoma. What is the recommended course of action for this patient? (INICET NOV 2021)</span></p>",
      "unique_key": "Q8070083",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250570,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Transurethral resection of the bladder tumour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For this patient diagnosed with bladder carcinoma, transurethral resection of bladder tumor (TURBT) is the most beneficial treatment option among the given choices. Based on the available evidence, there is no indication of muscle invasion or advanced cancer, suggesting that the most probable pathological stage is pTa - low grade non-muscle invasive cancer, for which TURBT followed by intravesical chemotherapy is the recommended treatment. TURBT is performed to pathologically stage the tumor and determine the appropriate course of treatment. Intravesical therapy using chemotherapy or immunotherapy is administered after TURBT to eradicate any residual cancer cells in the bladder lining, but it is not effective against cancers that have spread to muscle layers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct answer. TURBT is a standard initial procedure for diagnosing and treating visible tumors, especially for low-grade, noninvasive disease. It involves removing the tumor from the bladder wall via the urethra. The stage of the bladder cancer can be determined by examining the sample removed during a TURBT, which aids in further treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Resection with ileal conduit</strong>: This is a more invasive surgery typically used for muscle invasive bladder cancers (radical cystectomy). An ileal conduit is a urinary diversion technique where urine is redirected through a piece of the intestine and out to a stoma on the abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Partial cystectomy with bladder reconstruction</strong>: This involves removing a part of the bladder affected by cancer. It's reserved for select patients where the tumor is localized and not near the urethral or ureteral openings. It might not be the first line of treatment for a 2x2 cm low-grade tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Neo-adjuvant chemotherapy</strong>: This refers to chemotherapy given before a primary treatment in advanced cancers. In the case of bladder cancer, neo-adjuvant chemotherapy might be used before a surgery to shrink the tumor size or improve outcomes. However, for a low-grade, small tumor, it is not typically the first line of treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Non-muscle invasive bladder tumors (pTa/pT1): TUR-BT + Intravesical chemotherapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Muscle invasive (pT2/pT3 and some pT4): Radical cystectomy + Ileal conduit</strong></span></p>",
      "correct_choice_id": 56581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54788,
      "choices": [
        {
          "id": 218617,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Selenium</span></span></span></p>"
        },
        {
          "id": 218618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Copper</span></span></span></p>"
        },
        {
          "id": 218619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcium</span></span></span></p>"
        },
        {
          "id": 218620,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zinc</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which mineral is important for sexual maturation? (INICET MAY 2024)</span></span></p>",
      "unique_key": "Q9911853",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250555,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Zinc</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zinc is the mineral most crucial for sexual maturation. It plays a significant role in several biological processes related to growth and development, particularly in the reproductive system. Zinc is essential for the <strong>stabilization of cell membranes and has anti-inflammatory properties</strong>. Moreover, zinc is crucial for the <strong>proper functioning and development of sperm</strong>, which directly links it to sexual maturation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">One of the key reasons zinc is important in sexual maturation is because of its role in the formation of zinc finger motifs. These motifs are a type of protein structure that binds to DNA and plays a vital role in gene expression, including genes involved in the development of sexual characteristics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Selenium</span></strong><span style=\"font-size:12.0pt\">: Selenium is an essential trace element that plays a role in antioxidant defense and thyroid function. While it is important for general health, it is not as directly involved in sexual maturation as zinc.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Copper</span></strong><span style=\"font-size:12.0pt\">: Copper is important for various enzymatic reactions and the formation of red blood cells. Although it contributes to overall health, it is not specifically linked to sexual maturation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Calcium</span></strong><span style=\"font-size:12.0pt\">: Calcium is critical for bone health and muscle function, but it does not have a direct role in sexual maturation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zinc is the key mineral necessary for sexual maturation, particularly due to its role in the development and functioning of the reproductive system, including the formation of zinc finger motifs important for gene expression</span></span></span></p>",
      "correct_choice_id": 218620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24697,
      "choices": [
        {
          "id": 98749,
          "text": "<p><span style=\"font-size:12.0pt;\">500 ml/day</span></p>"
        },
        {
          "id": 98750,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5 ml/minute</span></p>"
        },
        {
          "id": 98751,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5-1.5 ml/kg/hour</span></p>"
        },
        {
          "id": 98752,
          "text": "<p><span style=\"font-size:12.0pt;\">1 ml/kg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the optimal urine output for a patient who has undergone laparoscopic cholecystectomy? </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
      "unique_key": "Q5413461",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250988,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 0.5-1.5 ml/kg/hour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">After a laparoscopic cholecystectomy, it is anticipated that the patient will have a normal urine output during the postoperative phase, which is 0.5-1.5 ml/kg/hour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If converted into ml/day, approximately 1500 ml/day in an avg. adult</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If converted into ml/minute, approximately 1 to 1.5 ml/minute in an avg. adult</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If converted into ml/kg, approximately 12-36 ml/day in an avg. adult</span></p>",
      "correct_choice_id": 98751,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73667,
      "choices": [
        {
          "id": 293609,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with neurofibromatosis</span></p>"
        },
        {
          "id": 293610,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant tumor with frequent metastasis</span></p>"
        },
        {
          "id": 293611,
          "text": "<p><span style=\"font-size:12.0pt;\">Originate from neural sheath</span></p>"
        },
        {
          "id": 293612,
          "text": "<p><span style=\"font-size:12.0pt;\">Verocay body on light microscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient presents with a swelling in the forearm. Microscopic examination reveals the following features. Which of the following statements is wrong regarding this condition? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_oW8r0zx.png\" width=\"469\" height=\"351\"></span></p>",
      "unique_key": "Q8009405",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250571,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B)&nbsp;Malignant tumor with frequent metastasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The image shows the characteristic microscopic appearance<strong>&nbsp;</strong>of a<strong> schwannoma, which shows hypercellular areas (Antoni A) and hypocellular areas (Antoni B) with Verocay bodies (nuclear palisading).&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Schwannomas are benign&nbsp;</strong>peripheral nerve sheath tumors that originate from<strong> Schwann cells.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Schwannomas are&nbsp;</strong>associated with<strong> neurofibromatosis type 2 (NF2) and show nuclear palisading.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The statement that it is a<strong> \"malignant tumor with frequent metastasis\" is incorrect&nbsp;</strong>because schwannomas are benign tumors with<strong> excellent prognosis and do not typically metastasize.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>SCHWANNOMA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Peripheral Nerve sheath tumor</span></li><li><span style=\"font-size:16px;\">Benign</span></li><li><span style=\"font-size:16px;\">Arises from Schwann cells of Peripheral nerves or Cranial nerves (8th CN &gt; 5th CN)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Risk factor:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">NF2 gene mutation causes reduced merlin expression and increased cell multiplication</span></li><li><span style=\"font-size:16px;\">B/L schwannoma due to NF-2 gene mutation</span></li><li><span style=\"font-size:16px;\">Schwannoma arising from 8th CN was earlier called acoustic neuroma</span></li><li><span style=\"font-size:16px;\">Now called as vestibular schwannoma</span></li><li><span style=\"font-size:16px;\">C/F: SNHL, tinnitus, decreased corneal reflex</span></li><li><span style=\"font-size:16px;\">Diagnosed with MRI</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Histology shows</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:16px;\">Hypercellular Antony 'A' area and hypocellular Antony 'B' area</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Antony 'A' area: tumor cells arranged in fence-like pattern  nuclear-free zones called verocay bodies</span></li></ul></li><li><span style=\"font-size:16px;\">Verocay body: Nuclear free area</span></li><li><span style=\"font-size:16px;\">Presence of true palisading</span></li><li><span style=\"font-size:16px;\">IHC shows S100+</span></li></ol><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-06-05%20124320.jpg\" width=\"613\" height=\"442\"></p>",
      "correct_choice_id": 293610,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11099,
      "choices": [
        {
          "id": 44362,
          "text": "<p><span style=\"font-size:18px;\">Absorption through skin</span></p>"
        },
        {
          "id": 44363,
          "text": "<p><span style=\"font-size:18px;\">Inhaled lead dust</span></p>"
        },
        {
          "id": 44364,
          "text": "<p><span style=\"font-size:18px;\">Ingestion of contaminated food and water</span></p>"
        },
        {
          "id": 44365,
          "text": "<p><span style=\"font-size:18px;\">Contaminated hands</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 45-year-old male worker presents to the emergency room with abdominal pain, irritability, fatigue, and memory problems. He works in a battery manufacturing factory for the last 20 years. On further investigations, he is diagnosed with lead poisoning. Which of the following is the most frequent mode of inorganic lead absorption contributing to his condition in such industrial environments? [</strong><i><strong>INICET MAY 2021]</strong></i></span></p>",
      "unique_key": "Q8788013",
      "question_audio": null,
      "question_video": null,
      "map_id": 23250507,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Inhaled lead dust</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In industrial environments such as battery manufacturing factories, the most frequent mode of inorganic lead absorption is through inhalation of lead dust.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Lead Poisoning is known as Plumbism, Saturnism or Painters Colic</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Greatest source of lead in Lead Poisoning (Plumbism, Saturnism or Painters Colic) is <strong>Gasoline/petrol</strong>/vehicular exhaust/automobile exhaust</span></li><li><span style=\"font-size:18px;\">Mode of absorption: Lead can be absorbed by<strong> inhalation (most common mode),</strong> ingestion or through skin</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Clinical picture of lead poisoning:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Facial pallor: Earliest and most consistent sign</span></li><li><span style=\"font-size:18px;\">Anemia: Microcytic hypochromic</span></li><li><span style=\"font-size:18px;\">Punctate basophilia or basophilic stippling of RBCs</span></li><li><span style=\"font-size:18px;\"><strong>Burtonian Line: Lead sulphide line on gums (upper jaw)</strong></span></li><li><span style=\"font-size:18px;\">Lead colic: Constipation (but sometimes diarrhea)</span></li><li><span style=\"font-size:18px;\">Lead Palsy (Peripheral neuropathy): Wrist drop or Foot drop</span></li><li><span style=\"font-size:18px;\">Lead encephalopathy</span></li><li><span style=\"font-size:18px;\">CNS effects: mostly due to organic lead compounds</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Diagnosis of lead poisoning:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/screenshot-2023-10-27-183620.jpg\" alt=\"\" width=\"800\" height=\"384\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A useful screening test is Coproporphyrin in Urine (CPU).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Treatment: EDTA</span></p>",
      "correct_choice_id": 44363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54760,
      "choices": [
        {
          "id": 218505,
          "text": "<p><span style=\"font-size:18px;\">Red</span></p>"
        },
        {
          "id": 218506,
          "text": "<p><span style=\"font-size:18px;\">Yellow</span></p>"
        },
        {
          "id": 218507,
          "text": "<p><span style=\"font-size:18px;\">Green</span></p>"
        },
        {
          "id": 218508,
          "text": "<p><span style=\"font-size:18px;\">Black</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Under categorization of triage, the immediately life-threatening injuries would be classified as under the color-coded category:&nbsp;[</strong><i><strong>INICET MAY 2024]</strong></i></span></p>",
      "unique_key": "Q2908956",
      "question_audio": null,
      "question_video": null,
      "map_id": 23251043,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Red</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The triage system is used in disaster management to categorize victims based on the <strong>severity of their condition and the likelihood of survival.</strong> Immediate life-threatening injuries, where a person could die or develop severe complications if no intervention is made within 0 to 6 hours, are classified under the <strong>Red</strong> category. This category is designated for emergent cases that require immediate medical attention to prevent death or severe complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Yellow</strong>: This category is for urgent cases where intervention is needed within 6 to 24 hours, such as resuscitation or limb/life-saving surgery. Although these injuries are serious, they are not as immediately life-threatening as those in the Red category.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Green</strong>: This category is for non-urgent cases involving minor injuries like fractures, bruises, or lacerations. Patients in this category are ambulatory and can wait for treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Black</strong>: This category is for patients who are either deceased or moribund (about to die). It represents the least priority in triage, as these patients have little to no chance of survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Triage Tagging system</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-102229.png\" alt=\"\" width=\"1000\" height=\"291\"></strong></span></p>",
      "correct_choice_id": 218505,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}